Placeholder Content Image

How long does immunity last after a COVID infection?

<p><em><a href="https://theconversation.com/profiles/lara-herrero-1166059">Lara Herrero</a>, <a href="https://theconversation.com/institutions/griffith-university-828">Griffith University</a> and <a href="https://theconversation.com/profiles/dr-wesley-freppel-1408971">Dr Wesley Freppel</a>, <a href="https://theconversation.com/institutions/griffith-university-828">Griffith University</a></em></p> <p>Nearly four years into the pandemic, Australia, like many other countries, is still seeing large numbers of <a href="https://nindss.health.gov.au/pbi-dashboard/">COVID cases</a>. Some 860,221 infections were recorded around the country in 2023, while 30,283 cases have already been reported in 2024.</p> <p>This is likely to be a significant underestimate, with fewer people testing and reporting than earlier in the pandemic. But the signs suggest parts of Australia are experiencing yet <a href="https://www.abc.net.au/news/2024-01-23/covid-19-case-numbers-from-australia-states-and-territories/103374656">another COVID surge</a>.</p> <p>While some lucky people claim to have never had COVID, many are facing our second, third or even fourth infection, often despite having been vaccinated. You might be wondering, how long does immunity last after a previous infection or vaccination?</p> <p>Let’s take a look at what the evidence shows.</p> <h2>B cells and T cells</h2> <p>To answer this question, we need to understand a bit about how <a href="https://theconversation.com/what-happens-in-our-body-when-we-encounter-and-fight-off-a-virus-like-the-flu-sars-cov-2-or-rsv-207023">immunity</a> to SARS-CoV-2 (the virus that causes COVID) works.</p> <p>After being infected or vaccinated, the immune system develops specific antibodies that can neutralise SARS-CoV-2. B cells remember the virus for a period of time. In addition, the immune system produces memory T cells that can kill the virus, and remain in the blood for some months after the clearance of the infection or a vaccination.</p> <p>A <a href="https://www.science.org/doi/full/10.1126/science.abf4063?rfr_dat=cr_pub++0pubmed&amp;url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org">2021 study</a> found 98% of people had antibodies against SARS-CoV-2’s spike protein (a protein on the surface of the virus that allows it to attach to our cells) one month after symptom onset. Six to eight months afterwards, 90% of participants still had these neutralising antibodies in their blood.</p> <p>This means the immune system should have recognised and neutralised the same SARS-CoV-2 variant if challenged within six to eight months (if an infection occurred, it should have resulted in mild to no symptoms).</p> <h2>But what about when the virus mutates?</h2> <p>As we know, SARS-CoV-2 has mutated over time, leading to the emergence of new variants such as alpha, beta, delta and omicron. Each of these variants carries mutations that are new to the immune system, even if the person has been previously infected with an earlier variant.</p> <p>A new variant likely won’t be <a href="https://www.science.org/doi/10.1126/science.adj0070">perfectly recognised</a> – or even <a href="https://www.cell.com/cell/pdf/S0092-8674(21)01578-6.pdf">recognised at all</a> – by the already activated memory T or B cells from a previous SARS-CoV-2 infection. This could explain why people can be so readily reinfected with COVID.</p> <p>A recent <a href="https://www.thelancet.com/article/S0140-6736(22)02465-5/fulltext#seccestitle10">review of studies</a> published up to the end of September 2022 looked at the protection conferred by previous SARS-CoV-2 infections.</p> <p>The authors found a previous infection provided protective immunity against reinfection with the ancestral, alpha, beta and delta variants of 85.2% at four weeks. Protection against reinfection with these variants remained high (78.6%) at 40 weeks, or just over nine months, after the previous infection. This protection decreased to 55.5% at 80 weeks (18 months), but the authors noted there was a lack of data at this time point.</p> <p>Notably, an earlier infection provided only 36.1% protection against a reinfection with omicron BA.1 at 40 weeks. Omicron has been described as an <a href="https://www.nature.com/articles/s41564-022-01143-7">immune escape variant</a>.</p> <p>A prior infection showed a high level of protection against severe disease (above 88%) up to 40 weeks regardless of the variant a person was reinfected with.</p> <h2>What about immunity after vaccination?</h2> <p>So far almost 70 million COVID vaccines <a href="https://www.health.gov.au/topics/covid-19/reporting">have been administered</a> to more than <a href="https://www.health.gov.au/resources/publications/covid-19-vaccine-rollout-update-12-january-2023?language=en">22 million people</a> in Australia. Scientists estimated COVID vaccines prevented around <a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00320-6/fulltext">14.4 million deaths</a> in 185 countries in the first year after they became available.</p> <p>But we know COVID vaccine effectiveness wanes over time. A <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804451?utm_source=For_The_Media&amp;utm_medium=referral&amp;utm_campaign=ftm_links&amp;utm_term=050323">2023 review</a> found the original vaccines were 79.6% and 49.7% effective at protecting against symptomatic delta infection at one and nine months after vaccination respectively. They were 60.4% and 13.3% effective against symptomatic omicron at the same time points.</p> <p>This is where booster doses come into the picture. They’re important to keep the immune system ready to fight off the virus, particularly for those who are more vulnerable to the effects of a COVID infection.</p> <p>Plus, regular booster doses can provide immunity against different variants. COVID vaccines are constantly being <a href="https://mvec.mcri.edu.au/references/covid-19/">reviewed and updated</a> to ensure optimal protection against <a href="https://www.who.int/activities/tracking-SARS-CoV-2-variants">current circulating strains</a>, with the latest shot available designed to target <a href="https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/new-covid-19-vaccines-available-to-target-current-variants">the omicron variant XBB 1.5</a>. This is similar to how we approach seasonal flu vaccines.</p> <p>A <a href="https://www.nature.com/articles/s41598-023-50335-6">recent study</a> showed a COVID vaccination provides longer protection against reinfection than natural protection alone. The median time from infection to reinfection in non-vaccinated people was only six months, compared with 14 months in people who had received one, two or three doses of vaccine after their first infection. This is called <a href="https://www.science.org/doi/10.1126/science.abj2258">hybrid immunity</a>, and other research has similarly found it provides better protection than natural infection alone.</p> <p>It also seems timing is important, as receiving a vaccine too soon after an infection (less than six months) appears to be <a href="https://www.nature.com/articles/s41598-023-50335-6">less effective</a> than getting vaccinated later.</p> <h2>What now?</h2> <p>Everyone’s immune system is slightly unique, and SARS-CoV-2 continues to mutate, so knowing exactly how long COVID immunity lasts is complicated.</p> <p>Evidence suggests immunity following infection should generally last six months in healthy adults, and can be prolonged with vaccination. But there are exceptions, and all of this assumes the virus has not mutated so much that it “escapes” our immune response.</p> <p>While many people feel the COVID pandemic is over, it’s important we don’t forget the lessons we have learned. Practices such as wearing a mask and staying home when unwell can reduce the spread of many viruses, not only <a href="https://www.bmj.com/content/375/bmj-2021-068302">COVID</a>.</p> <p>Vaccination is not mandatory, but for older adults eligible for a booster under the <a href="https://www.health.gov.au/news/atagi-update-on-the-covid-19-vaccination-program">current guidelines</a>, it’s a very good idea.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/221398/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><a href="https://theconversation.com/profiles/lara-herrero-1166059"><em>Lara Herrero</em></a><em>, Research Leader in Virology and Infectious Disease, <a href="https://theconversation.com/institutions/griffith-university-828">Griffith University</a> and <a href="https://theconversation.com/profiles/dr-wesley-freppel-1408971">Dr Wesley Freppel</a>, Research Fellow, Institute for Glycomics, <a href="https://theconversation.com/institutions/griffith-university-828">Griffith University</a></em></p> <p><em>Image credits: Getty Images</em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/how-long-does-immunity-last-after-a-covid-infection-221398">original article</a>.</em></p>

Body

Placeholder Content Image

COVID is surging in Australia – and only 1 in 5 older adults are up to date with their boosters

<p><em><a href="https://theconversation.com/profiles/adrian-esterman-1022994">Adrian Esterman</a>, <a href="https://theconversation.com/institutions/university-of-south-australia-1180">University of South Australia</a></em></p> <p>Do you have family members or friends sick with a respiratory infection? If so, there’s a good chance it’s COVID, caused by the JN.1 variant currently circulating in Australia.</p> <p>In particular, New South Wales is reportedly experiencing its <a href="https://www.abc.net.au/news/2024-01-09/nsw-sydney-covid-variant-virus-pandemic-hospitalisations/103298610">highest levels</a> of COVID infections in a year, while Victoria is said to be facing a “<a href="https://www.9news.com.au/national/victoria-in-midst-of-double-wave-of-covid19--as-jn1-triggers-infections-surge/4dada2cb-7d56-436a-9490-cad1d908a29a">double wave</a>” after a surge late last year.</p> <p>But nearly four years into the pandemic, data collection is less comprehensive than it was, and of course, fewer people are testing. So what do we know about the extent of this wave? And importantly, are we adequately protected?</p> <h2>Difficulties with data</h2> <p>Tracking COVID numbers was easier in the first half of last year, when each state and territory provided a weekly update, giving us data on case notifications, hospitalisations, ICU numbers and deaths.</p> <p>In the second half of the year some states and territories switched to less frequent reporting while others stopped their regular updates. As a result, different jurisdictions now report at different intervals and provide varying statistics.</p> <p>For example, <a href="https://www.health.vic.gov.au/infectious-diseases/victorian-covid-19-surveillance-report">Victoria</a> still provides weekly reports, while NSW publishes <a href="https://www.health.nsw.gov.au/Infectious/covid-19/Documents/respiratory-surveillance-20240106.pdf">fortnightly updates</a>.</p> <p>While each offer different metrics, we can gather – particularly from data on hospitalisations – that both states are experiencing a wave. We’re also seeing high levels of COVID <a href="https://www.health.vic.gov.au/infectious-diseases/victorian-covid-19-surveillance-report">in wastewater</a>.</p> <p>Meanwhile, <a href="https://health.nt.gov.au/covid-19/data">Northern Territory Health</a> simply tell you to go to the Australian government’s Department of Health website for COVID data. This houses the only national COVID <a href="https://www.health.gov.au/topics/covid-19/reporting?language=und">data collection</a>. Unfortunately, it’s not up to date, difficult to use, and, depending on the statistic, often provides no state and territory breakdowns.</p> <p>Actual case notifications are provided on a separate <a href="https://nindss.health.gov.au/pbi-dashboard/">website</a>, although given the lack of testing, these are likely to be highly inaccurate.</p> <p>The <a href="https://www.health.gov.au/topics/covid-19/reporting?language=und">Department of Health website</a> does provide some other data that gives us clues as to what’s happening. For example, as of one month ago, there were 317 active outbreaks of COVID in aged care homes. This figure has been generally rising since September.</p> <p>Monthly prescriptions for antivirals on the Pharmaceutical Benefits Scheme were increasing rapidly in November, but we are not given more recent data on this.</p> <p>It’s also difficult to obtain information about currently circulating strains. Data expert Mike Honey provides a regularly updated <a href="https://github.com/Mike-Honey/covid-19-genomes?tab=readme-ov-file#readme">snapshot</a> for Australia based on data from GISAID (the Global Initiative on Sharing All Influenza Data) that shows JN.1 rising in prevalence and accounting for about 40% of samples two weeks ago. The proportion is presumably higher now.</p> <h2>What’s happening elsewhere?</h2> <p>Many other countries are currently going through a COVID wave, probably driven to a large extent by JN.1. These include <a href="https://www.rnz.co.nz/news/national/506301/covid-19-complacency-waning-immunity-contribute-to-fifth-wave-epidemiologist">New Zealand</a>, <a href="https://www.independent.co.uk/news/world/europe/facemasks-mandatory-spain-hospitals-b2475563.html">Spain, Greece</a> and the United States.</p> <p>According to cardiologist and scientist Eric Topol, the US is currently experiencing its <a href="https://www.latimes.com/opinion/story/2024-01-04/covid-2024-flu-virus-vaccine">second biggest wave</a> since the start of the pandemic, linked to JN.1.</p> <h2>Are vaccines still effective?</h2> <p>It’s expected the current COVID vaccines, which target the omicron variant XBB.1.5, are still <a href="https://www.gavi.org/vaccineswork/seven-things-you-need-know-about-jn1-covid-19-variant">effective</a> at reducing hospitalisations and deaths from JN.1 (also an omicron offshoot).</p> <p>The Australian Technical Advisory Group on Immunisation (ATAGI) updated their <a href="https://www.health.gov.au/news/atagi-update-on-the-covid-19-vaccination-program">advice</a> on booster shots in September last year. They recommended adults aged over 75 should receive an additional COVID vaccine dose in 2023 if six months had passed since their last dose.</p> <p>They also suggest all adults aged 65 to 74 (plus adults of any age who are severely immunocompromised) should consider getting an updated booster. They say younger people or older adults who are not severely immunocompromised and have already had a dose in 2023 don’t need further doses.</p> <p>This advice is very confusing. For example, although ATAGI does not recommend additional booster shots for younger age groups, does this mean they’re not allowed to have one?</p> <p>In any case, as of <a href="https://www.health.gov.au/resources/publications/covid-19-vaccine-rollout-update-8-december-2023?language=en">December 6</a>, only 19% of people aged 65 and over had received a booster shot in the last six months. For those aged 75 and over, this figure is 23%. Where is the messaging to these at-risk groups explaining why updating their boosters is so important?</p> <h2>Should we be concerned by this wave?</h2> <p>That depends on who we mean by “we”. For those who are vulnerable, absolutely. Mainly because so few have received an updated booster shot and very few people, including the elderly, are wearing masks.</p> <p>For the majority of people, a COVID infection is unlikely to be serious. The biggest concern for younger people is the risk of long COVID, which research suggests <a href="https://www.nature.com/articles/s41591-022-02051-3">increases</a> with each reinfection.</p> <h2>What should we expect in 2024?</h2> <p>It’s highly likely we will see repeated waves of infections over the next 12 months and beyond, mainly caused by waning immunity from previous infection, vaccination or both, and new subvariants.</p> <p>Unless a new subvariant causes more severe disease (and at this stage, there’s no evidence JN.1 does), we should be able to manage quite well, without our hospitals becoming overwhelmed. However, we should be doing more to protect our vulnerable population. Having only one in five older people up to date with a booster and more than 300 outbreaks in aged care homes is not acceptable.</p> <p>For those who are vulnerable, the usual advice applies. Make sure you’re up to date with your booster shots, wear a P2/N95 mask when out and about, and if you do get infected, take antivirals as soon as possible.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/220839/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><a href="https://theconversation.com/profiles/adrian-esterman-1022994"><em>Adrian Esterman</em></a><em>, Professor of Biostatistics and Epidemiology, <a href="https://theconversation.com/institutions/university-of-south-australia-1180">University of South Australia</a></em></p> <p><em>Image credits: Getty Images</em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/covid-is-surging-in-australia-and-only-1-in-5-older-adults-are-up-to-date-with-their-boosters-220839">original article</a>.</em></p>

Body

Placeholder Content Image

What are the new COVID booster vaccines? Can I get one? Do they work? Are they safe?

<p><em><a href="https://theconversation.com/profiles/paul-griffin-1129798">Paul Griffin</a>, <a href="https://theconversation.com/institutions/the-university-of-queensland-805">The University of Queensland</a></em></p> <p>As the COVID virus continues to <a href="https://pubmed.ncbi.nlm.nih.gov/36680207/">evolve</a>, so does our vaccine response. From <a href="https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/new-covid-19-vaccines-available-to-target-current-variants?language=en">December 11</a>, Australians will have access to <a href="https://www.health.gov.au/news/atagi-recommendations-on-use-of-the-moderna-and-pfizer-monovalent-omicron-xbb15-covid-19-vaccines?language=en">new vaccines</a> that offer better protection.</p> <p>These “monovalent” booster vaccines are expected to be a <a href="https://theconversation.com/cdc-greenlights-two-updated-covid-19-vaccines-but-how-will-they-fare-against-the-latest-variants-5-questions-answered-213341">better match</a> for currently circulating strains of SARS-CoV-2, the virus that causes COVID.</p> <p>Pfizer’s monovalent vaccine will be <a href="https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/new-covid-19-vaccines-available-to-target-current-variants?language=en">available</a> to eligible people aged five years and older. The Moderna monovalent vaccine can be used for those aged 12 years and older.</p> <p>Who is eligible for these new boosters? How do they differ from earlier ones? Do they work? Are they safe?</p> <h2>Who’s eligible for the new boosters?</h2> <p>The federal government has accepted the Australian Technical Advisory Group (ATAGI) recommendation to use the new vaccines, after Australia’s regulator <a href="https://www.tga.gov.au/products/covid-19/covid-19-vaccines/covid-19-vaccines-regulatory-status">approved their use last month</a>. However, vaccine eligibility has remained the same since September.</p> <p>ATAGI <a href="https://www.health.gov.au/news/atagi-recommendations-on-use-of-the-moderna-and-pfizer-monovalent-omicron-xbb15-covid-19-vaccines?language=en">recommends</a> Australians aged over 75 get vaccinated if it has been six months or more since their last dose.</p> <p>People aged 65 to 74 are recommended to have a 2023 booster if they haven’t already had one.</p> <figure class="align-center zoomable"><a href="https://images.theconversation.com/files/560533/original/file-20231120-21-4igdnx.png?ixlib=rb-1.1.0&amp;q=45&amp;auto=format&amp;w=1000&amp;fit=clip"><img src="https://images.theconversation.com/files/560533/original/file-20231120-21-4igdnx.png?ixlib=rb-1.1.0&amp;q=45&amp;auto=format&amp;w=754&amp;fit=clip" sizes="(min-width: 1466px) 754px, (max-width: 599px) 100vw, (min-width: 600px) 600px, 237px" srcset="https://images.theconversation.com/files/560533/original/file-20231120-21-4igdnx.png?ixlib=rb-1.1.0&amp;q=45&amp;auto=format&amp;w=600&amp;h=315&amp;fit=crop&amp;dpr=1 600w, https://images.theconversation.com/files/560533/original/file-20231120-21-4igdnx.png?ixlib=rb-1.1.0&amp;q=30&amp;auto=format&amp;w=600&amp;h=315&amp;fit=crop&amp;dpr=2 1200w, https://images.theconversation.com/files/560533/original/file-20231120-21-4igdnx.png?ixlib=rb-1.1.0&amp;q=15&amp;auto=format&amp;w=600&amp;h=315&amp;fit=crop&amp;dpr=3 1800w, https://images.theconversation.com/files/560533/original/file-20231120-21-4igdnx.png?ixlib=rb-1.1.0&amp;q=45&amp;auto=format&amp;w=754&amp;h=396&amp;fit=crop&amp;dpr=1 754w, https://images.theconversation.com/files/560533/original/file-20231120-21-4igdnx.png?ixlib=rb-1.1.0&amp;q=30&amp;auto=format&amp;w=754&amp;h=396&amp;fit=crop&amp;dpr=2 1508w, https://images.theconversation.com/files/560533/original/file-20231120-21-4igdnx.png?ixlib=rb-1.1.0&amp;q=15&amp;auto=format&amp;w=754&amp;h=396&amp;fit=crop&amp;dpr=3 2262w" alt="" /></a><figcaption><span class="caption">For people without risk factors.</span> <span class="attribution"><a class="source" href="https://www.health.gov.au/sites/default/files/2023-10/atagi-recommended-covid-19-vaccine-doses.pdf">Health.gov.au</a></span></figcaption></figure> <p>Adults aged 18 to 64 <em>with</em> underlying risk factors that increase their risk of severe COVID are also recommended to have a 2023 booster if they haven’t had one yet. And if they’ve already had a 2023 booster, they can consider an additional dose.</p> <figure class="align-center zoomable"><a href="https://images.theconversation.com/files/560532/original/file-20231120-26-70jfyr.png?ixlib=rb-1.1.0&amp;q=45&amp;auto=format&amp;w=1000&amp;fit=clip"><img src="https://images.theconversation.com/files/560532/original/file-20231120-26-70jfyr.png?ixlib=rb-1.1.0&amp;q=45&amp;auto=format&amp;w=754&amp;fit=clip" sizes="(min-width: 1466px) 754px, (max-width: 599px) 100vw, (min-width: 600px) 600px, 237px" srcset="https://images.theconversation.com/files/560532/original/file-20231120-26-70jfyr.png?ixlib=rb-1.1.0&amp;q=45&amp;auto=format&amp;w=600&amp;h=311&amp;fit=crop&amp;dpr=1 600w, https://images.theconversation.com/files/560532/original/file-20231120-26-70jfyr.png?ixlib=rb-1.1.0&amp;q=30&amp;auto=format&amp;w=600&amp;h=311&amp;fit=crop&amp;dpr=2 1200w, https://images.theconversation.com/files/560532/original/file-20231120-26-70jfyr.png?ixlib=rb-1.1.0&amp;q=15&amp;auto=format&amp;w=600&amp;h=311&amp;fit=crop&amp;dpr=3 1800w, https://images.theconversation.com/files/560532/original/file-20231120-26-70jfyr.png?ixlib=rb-1.1.0&amp;q=45&amp;auto=format&amp;w=754&amp;h=391&amp;fit=crop&amp;dpr=1 754w, https://images.theconversation.com/files/560532/original/file-20231120-26-70jfyr.png?ixlib=rb-1.1.0&amp;q=30&amp;auto=format&amp;w=754&amp;h=391&amp;fit=crop&amp;dpr=2 1508w, https://images.theconversation.com/files/560532/original/file-20231120-26-70jfyr.png?ixlib=rb-1.1.0&amp;q=15&amp;auto=format&amp;w=754&amp;h=391&amp;fit=crop&amp;dpr=3 2262w" alt="" /></a><figcaption><span class="caption">Advice for people with risk factors.</span> <span class="attribution"><a class="source" href="https://www.health.gov.au/sites/default/files/2023-10/atagi-recommended-covid-19-vaccine-doses.pdf">Health.gov.au</a></span></figcaption></figure> <p>For adults aged 18 to 64 <em>without</em> underlying risk factors who have already received a 2023 booster, an additional dose isn’t recommended. But if you’re aged 18 to 64 and haven’t had a booster in 2023, you can consider an additional dose.</p> <p>Additional doses aren’t recommended for children <em>without</em> underlying conditions that increase their risk of severe COVID. A primary course is not recommended for children aged six months to five years <em>without</em> additional risk factors.</p> <h2>Monovalent, bivalent? What’s the difference?</h2> <p><strong>From monovalent</strong></p> <p>The initial COVID vaccines were “monovalent”. They had one target – the original viral strain.</p> <p>But as the virus mutated, we assigned new letters of the Greek alphabet to each variant. This brings us to Omicron. With this significant change, we saw “immune evasion”. The virus had changed so much the original vaccines didn’t provide sufficient immunity.</p> <p><strong>To bivalent</strong></p> <p>So vaccines were updated to target an early Omicron subvariant, BA.1, plus the original ancestral strain. With two targets, these were the first of the “bivalent” vaccines, which were approved in Australia <a href="https://theconversation.com/omicron-specific-vaccines-may-give-slightly-better-covid-protection-but-getting-boosted-promptly-is-the-best-bet-190736">in 2022</a>.</p> <p>Omicron continued to evolve, leading to more “immune escape”, contributing to repeated waves of transmission.</p> <p>The vaccines were updated again in <a href="https://theconversation.com/havent-had-covid-or-a-vaccine-dose-in-the-past-six-months-consider-getting-a-booster-199096">early 2023</a>. These newer bivalent vaccines target two strains – the ancestral strain plus the subvariants BA.4 and BA.5.</p> <p><strong>Back to monovalent</strong></p> <p>Further changes in the virus have meant our boosters needed to be updated again. This takes us to the recent announcement.</p> <p>This time the booster targets another subvariant of Omicron known as XBB.1.5 (sometimes known as <a href="https://theconversation.com/the-kraken-subvariant-xbb-1-5-sounds-scary-but-behind-the-headlines-are-clues-to-where-covids-heading-198158">Kraken</a>).</p> <p>This vaccine is monovalent once more, meaning it has only one target. The target against the original viral strain has been removed.</p> <p>According to advice given to the World Health Organization <a href="https://www.who.int/news/item/18-05-2023-statement-on-the-antigen-composition-of-covid-19-vaccines">in May</a>, this is largely because immunity to this original strain is no longer required (it’s no longer infecting humans). Raising immunity to the original strain may also hamper the immune response to the newer component, but we’re not sure if this is occurring or how important this is.</p> <p>The United States <a href="https://theconversation.com/cdc-greenlights-two-updated-covid-19-vaccines-but-how-will-they-fare-against-the-latest-variants-5-questions-answered-213341">approved</a> XBB.1.5-specific vaccines from Pfizer and Moderna in <a href="https://www.fda.gov/news-events/press-announcements/fda-takes-action-updated-mrna-covid-19-vaccines-better-protect-against-currently-circulating">mid-September</a>. These updated vaccines have also been <a href="https://www.tga.gov.au/sites/default/files/2023-10/auspar-spikevax-xbb.1.5-231012.pdf">approved in</a> places including Europe, Canada, Japan and Singapore.</p> <p>In Australia, the Therapeutic Goods Administration (TGA) approved them <a href="https://www.tga.gov.au/products/covid-19/covid-19-vaccines/covid-19-vaccines-regulatory-status">in October</a>.</p> <h2>Do these newer vaccines work?</h2> <p>Evidence for the efficacy of these new monovalent vaccines comes from the results of research <a href="https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&amp;id=CP-2023-PI-02409-1&amp;d=20231117172310101">Pfizer</a> and <a href="https://www.tga.gov.au/resources/auspar/auspar-spikevax-xbb15">Moderna</a> submitted to the TGA.</p> <p>Evidence also comes from a <a href="https://www.medrxiv.org/content/10.1101/2023.08.22.23293434v2">preprint</a> (preliminary research available online that has yet to be independently reviewed) and an update Pfizer <a href="https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2023-09-12/10-COVID-Modjarrad-508.pdf">presented</a> to the US Centers for Disease Control.</p> <p>Taken together, the available evidence shows the updated vaccines produce good levels of antibodies in <a href="https://www.tga.gov.au/resources/auspar/auspar-spikevax-xbb15">laboratory studies</a>, <a href="https://www.medrxiv.org/content/10.1101/2023.08.22.23293434v2">in humans</a> and <a href="https://www.tga.gov.au/resources/auspar/auspar-spikevax-xbb15">mice</a> when compared to previous vaccines and when looking at multiple emerging variants, including EG.5 (sometimes known as <a href="https://theconversation.com/the-who-has-declared-eris-a-variant-of-interest-how-is-it-different-from-other-omicron-variants-211276">Eris</a>). This variant is the one causing high numbers of cases around the world currently, including in Australia. It is very similar to the XBB version contained in the updated booster.</p> <p>The updated vaccines should also cover <a href="https://theconversation.com/how-evasive-and-transmissible-is-the-newest-omicron-offshoot-ba-2-86-that-causes-covid-19-4-questions-answered-212453">BA.2.86 or Pirola</a>, according to <a href="https://www.tga.gov.au/sites/default/files/2023-10/auspar-spikevax-xbb.1.5-231012.pdf">early results</a> from clinical trials and the US <a href="https://www.cdc.gov/respiratory-viruses/whats-new/covid-19-variant.html">Centers for Disease Control</a>. This variant is responsible for a rapidly increasing proportion of cases, with case numbers growing <a href="https://twitter.com/BigBadDenis/status/1725310295596560662?s=19">in Australia</a>.</p> <p>It’s clear the virus is going to continue to evolve. So performance of these vaccines against new variants will continue to be closely monitored.</p> <h2>Are they safe?</h2> <p>The <a href="https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&amp;id=CP-2023-PI-02409-1&amp;d=20231117172310101">safety</a> of the updated vaccines has also been shown to be similar to previous versions. Studies <a href="https://www.medrxiv.org/content/10.1101/2023.08.22.23293434v2">comparing them</a> found no significant difference in terms of the adverse events reported.</p> <p>Given the availability of the updated vaccines, some countries have removed their approval for earlier versions. This is because newer versions are a closer match to currently circulating strains, rather than any safety issue with the older vaccines.</p> <h2>What happens next?</h2> <p>The availability of updated vaccines is a welcome development, however this is not the end of the story. We need to make sure eligible people get vaccinated.</p> <p>We also need to acknowledge that vaccination should form part of a comprehensive strategy to limit the impact of COVID from now on. That includes measures such as mask wearing, social distancing, focusing on ventilation and air quality, and to a lesser degree hand hygiene. Rapidly accessing antivirals if eligible is also still important, as is keeping away from others if you are infected.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/217804/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><a href="https://theconversation.com/profiles/paul-griffin-1129798"><em>Paul Griffin</em></a><em>, Professor, Infectious Diseases and Microbiology, <a href="https://theconversation.com/institutions/the-university-of-queensland-805">The University of Queensland</a></em></p> <p><em>Image credits: Getty Images</em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/what-are-the-new-covid-booster-vaccines-can-i-get-one-do-they-work-are-they-safe-217804">original article</a>.</em></p>

Body

Placeholder Content Image

A COVID inquiry has been announced. But is COVID still a thing? Do I need a booster?

<p><em><a href="https://theconversation.com/profiles/michael-toole-18259">Michael Toole</a>, <a href="https://theconversation.com/institutions/burnet-institute-992">Burnet Institute</a>; <a href="https://theconversation.com/profiles/heidi-drummer-1472642">Heidi Drummer</a>, <a href="https://theconversation.com/institutions/burnet-institute-992">Burnet Institute</a>, and <a href="https://theconversation.com/profiles/suman-majumdar-117988">Suman Majumdar</a>, <a href="https://theconversation.com/institutions/burnet-institute-992">Burnet Institute</a></em></p> <p>Thursday’s <a href="https://www.abc.net.au/news/2023-09-21/inquiry-to-be-announced-into-aus-government-covid-19-response/102882616">announcement</a> <a href="https://www.pm.gov.au/media/improving-future-preparedness-inquiry-response-covid-19-pandemic">of an independent inquiry</a> into Australia’s COVID response will examine how we’ve handled the pandemic and how we could better prepare for the next one.</p> <p>But the pandemic is not just a once-in-a-lifetime event that’s over and needs to be analysed. It’s still with us.</p> <p>The Omicron variant <a href="https://theconversation.com/how-evasive-and-transmissible-is-the-newest-omicron-offshoot-ba-2-86-that-causes-covid-19-4-questions-answered-212453">continues to mutate</a> and <a href="https://www.abc.net.au/news/2023-09-21/new-covid-strain-variant-pirola-ba-2-86-in-australia-symptoms/102873304">new sub-variants</a> emerge. For instance, the highly-mutated BA.2.86 (known as Pirola) has just been <a href="https://www.abc.net.au/news/2023-09-21/new-covid-strain-variant-pirola-ba-2-86-in-australia-symptoms/102873304">detected</a> in Australia.</p> <p>The SARS-CoV-2 virus, which causes COVID, then becomes more adept at evading immunity from infections and vaccines.</p> <p>COVID is not yet predictably seasonal and we expect waves every three to six months. The United States has seen a <a href="https://covid.cdc.gov/covid-data-tracker/#trends_weeklyhospitaladmissions_select_00">threefold increase</a> in hospitalisations since mid-July due to waning immunity and the <a href="https://theconversation.com/the-who-has-declared-eris-a-variant-of-interest-how-is-it-different-from-other-omicron-variants-211276">EG.5 sub-variant</a> (known as Eris).</p> <p>The United Kingdom has also seen a <a href="https://twitter.com/DrEricDing/status/1702790082749448202?t=FLc5f9FoMS6ksioFS8ATpA&amp;s=09">significant increase</a> in adult and child hospitalisations due to COVID in the past month.</p> <p>In Australia, more than <a href="https://www.worldometers.info/coronavirus/country/australia/">5,000 people</a> have died due to COVID so far this year. Excess deaths from any cause are <a href="https://www.abs.gov.au/statistics/health/causes-death/provisional-mortality-statistics/latest-release">13% higher</a> than expected. We expect many of these are related to COVID.</p> <p>The median age of COVID deaths is <a href="https://www.abs.gov.au/articles/covid-19-mortality-australia-deaths-registered-until-31-july-2023">around 85 years old</a> in Australia. But there were 267 reported deaths in people under 50 until the end of July 2023; some may have had weaker immune systems.</p> <p>The impacts of <a href="https://www.aph.gov.au/longandrepeatedcovid">long COVID and re-infections</a> are significant, which <a href="https://www.abc.net.au/news/2022-07-20/younger-active-female-data-reveals-long-covid-profile/101251352">one study shows</a> mainly affects people of working age and most commonly women.</p> <h2>I’ve had a booster. Does that still protect me?</h2> <p>We know immunity from COVID vaccines wanes over time. In a paper published in May, a <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804451?utm_source=For_The_Media&amp;utm_medium=referral&amp;utm_campaign=ftm_links&amp;utm_term=050323">systematic review</a> of 40 studies showed by how much. Protection by the first two doses of the vaccine (known as the primary series) against symptomatic infection from Omicron waned from almost 53% one month after the second dose to just over 14% after six months.</p> <p>The same review found a booster (third or fourth dose) increased protective immunity to the same levels as the primary series. However, that immunity waned to just 30% nine months later.</p> <p>A number of studies have shown protection against severe disease and death from the Omicron variant also wanes over time. For example, <a href="https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00365-1/fulltext#seccestitle10">a UK study</a> found a primary series plus a bivalent booster (targets two strains) provided 53% protection against hospitalisation four weeks after the booster among people aged 50 or over. Protection dropped to 36% at ten weeks.</p> <p>An <a href="https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4445191">Australian study</a>, yet to be independently verified by other researchers, suggests protection against death from COVID also wanes. Of 3.8 million adults over 65 years, protection of a third dose booster against death from COVID waned from an estimated 93% within three months to 56% after six months.</p> <p>So we believe a reasonable interpetation of the above data is to recommend a booster every six months in people aged 75 and older, and younger people with impaired immune systems.</p> <p>But in Australia, just over <a href="https://www.health.gov.au/sites/default/files/2023-09/covid-19-vaccine-rollout-update-15-september-2023.pdf">50%</a> of people aged 75 or older have received a booster in the past six months; only about 38% of people aged 65-74 and about 9% in those aged 18-64 years.</p> <h2>I’ve had COVID recently. Surely that’s enough</h2> <p>There is a widespread perception that if you’ve been infected with COVID and have had the primary series of the vaccine then you’re immune and, therefore, don’t need to get a booster. This is commonly described as having “hybrid immunity”.</p> <p>However, a very <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02465-5/fulltext">large study</a> across 19 countries found infection conferred different levels of immunity, depending on the variant. While infection with COVID effectively protected against reinfection by the original, Alpha, Beta and Delta variants, this was much less effective against the Omicron BA.1 variant. Since BA.1, there have been many new sub-variants that are even more adept at evading immunity.</p> <h2>Who can get a booster?</h2> <p>Earlier this month, the Australian Technical Advisory Group on Immunisation (ATAGI) <a href="https://www.health.gov.au/news/atagi-update-on-the-covid-19-vaccination-program">recommended</a> all adults aged 75 or older “should receive” an additional dose of the bivalent vaccine if six months have passed since their last dose. Additionally, people aged 65-74 and immunocompromised younger adults should “consider” an additional dose.</p> <p>ATAGI argues that the baseline risk of severe illness in people under 65 is low if they have already been vaccinated, and particularly if they have also been infected. So, a further 2023 dose for this group would offer little additional benefit, even if it has been more than six months since their last dose.</p> <p>The US has taken a different approach. Last week, the Centers for Disease Control and Prevention <a href="https://www.cdc.gov/media/releases/2023/p0912-COVID-19-Vaccine.html">recommended</a> all people over six months who have not received a COVID vaccine in the previous two months should get a dose of the newly approved monovalent (single strain) vaccines. These have been developed by Pfizer and Moderna to specifically <a href="https://www.fda.gov/news-events/press-announcements/fda-takes-action-updated-mrna-covid-19-vaccines-better-protect-against-currently-circulating">target the XBB.1.5</a> sub-variant of Omicron. <a href="https://www.canada.ca/en/health-canada/news/2023/09/health-canada-authorizes-moderna-covid-19-vaccine-targeting-the-omicron-xbb15-subvariant.html">Health Canada</a> has adopted similar recommendations.</p> <p>These new monovalent vaccines are expected <a href="https://www.science.org/content/article/should-i-get-covid-19-booster">to be effective</a> in preventing infection by recently emerging Omicron sub-variants, such as EG.5 and FL.1.51 derived from the XBB.1.5 sub-variant, and the newer highly mutated <a href="https://www.gov.uk/government/publications/investigation-of-sars-cov-2-variants-of-concern-variant-risk-assessments/risk-assessment-for-sars-cov-2-variant-v-23aug-01-or-ba286">BA.2.86</a>, which arose from an earlier sub-variant and is a significant evolutionary leap.</p> <p>While Canada and the US move into the northern hemisphere winter, Australians should not believe they are at lower risk during the summer. After all, <a href="https://www.worldometers.info/coronavirus/country/australia/">two large COVID waves</a> in Australia were in the summers of 2021/22 and 2022/23.</p> <p>Monovalent XBB.1.5 vaccines are not yet available in Australia, but are being evaluated by the <a href="https://www.tga.gov.au/products/covid-19/covid-19-vaccines/covid-19-vaccines-regulatory-status">Therapeutic Goods Administration</a>. So, in the future, Australia’s advice about who’s eligible for a booster, and which type of booster, may change.</p> <h2>So, how do I decide if I need a booster now?</h2> <p>There is evidence in Australia of <a href="https://www.abc.net.au/news/2023-09-21/new-covid-strain-variant-pirola-ba-2-86-in-australia-symptoms/102873304">growth of</a> the newer subvariants, including the detection of BA.2.86. So all Australians aged 75 and over who have not had a booster in the past six months should immediately have the currently available bivalent vaccine.</p> <p>Younger age groups may wait until further ATAGI advice about the new monovalent vaccines.</p> <h2>COVID is not over</h2> <p>While there is no need for alarm, Australians need to be aware of the ongoing significant impacts of COVID. The SARS-CoV-2 virus is still a formidable foe as it continues to mutate.</p> <p>COVID vaccines will be <a href="https://www.pm.gov.au/media/improving-future-preparedness-inquiry-response-covid-19-pandemic">among the topics</a> the newly announced inquiry will investigate.</p> <p>But we cannot rely on vaccines alone. Avoiding (re)infection is also vital. Breathe <a href="https://www.coronavirus.vic.gov.au/ventilation">clean indoor air</a>, wear <a href="https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/types-of-masks.html">high quality masks</a> and get tested so you can access <a href="https://www.health.gov.au/health-alerts/covid-19/treatments/eligibility">antivirals</a> if eligible.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/213469/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><a href="https://theconversation.com/profiles/michael-toole-18259"><em>Michael Toole</em></a><em>, Associate Principal Research Fellow, <a href="https://theconversation.com/institutions/burnet-institute-992">Burnet Institute</a>; <a href="https://theconversation.com/profiles/heidi-drummer-1472642">Heidi Drummer</a>, Professor and Co-Program Director, Disease Elimination, <a href="https://theconversation.com/institutions/burnet-institute-992">Burnet Institute</a>, and <a href="https://theconversation.com/profiles/suman-majumdar-117988">Suman Majumdar</a>, Associate Professor and Chief Health Officer - COVID and Health Emergencies, <a href="https://theconversation.com/institutions/burnet-institute-992">Burnet Institute</a></em></p> <p><em>Image credits: Getty Images</em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/a-covid-inquiry-has-been-announced-but-is-covid-still-a-thing-do-i-need-a-booster-213469">original article</a>.</em></p>

Body

Placeholder Content Image

How biological differences between men and women alter immune responses – and affect women’s health

<p><a href="https://theconversation.com/profiles/helen-mcgettrick-1451122">Helen McGettrick</a>, <em><a href="https://theconversation.com/institutions/university-of-birmingham-1138">University of Birmingham</a></em> and <a href="https://theconversation.com/profiles/asif-iqbal-1451123">Asif Iqbal</a>, <em><a href="https://theconversation.com/institutions/university-of-birmingham-1138">University of Birmingham</a></em></p> <p>Most people will have heard the term “man flu”, which refers to men’s perceived tendency to exaggerate the severity of a cold or a similar minor ailment.</p> <p>What most people may not know is that, generally speaking, women mount stronger <a href="https://pubmed.ncbi.nlm.nih.gov/36121220/">immune responses</a> to infections than men. Men are <a href="https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005374">more susceptible</a> to infections from, for example, HIV, hepatitis B, and <em>Plasmodium falciparum</em> (the parasite responsible for malaria).</p> <p>They can also have more severe symptoms, with evidence showing they’re more likely to be <a href="https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1005374">admitted to hospital</a> when infected with hepatitis B, tuberculosis, and <em>Campylobacter jejuni</em> (a bacteria that causes gastroenteritis), among others.</p> <p>While this may be positive for women in some respects, it also means women are at <a href="https://www.nature.com/articles/nri2815">greater risk</a> of developing chronic diseases driven by the immune system, known as immune-mediated inflammatory diseases.</p> <p>Here we will explore how biological factors influence immune differences between the sexes and how this affects women’s health. While we acknowledge that both sex and gender may affect immune responses, this article will focus on biological sex rather than gender.</p> <h2>Battle of the sexes</h2> <p>There are differences <a href="https://www.nature.com/articles/nri.2016.90">between the sexes</a> at every stage of the immune response, from the number of immune cells, to their degree of activation (how ready they are to respond to a challenge), and beyond.</p> <p>However, the story is more complicated than that. Our immune system evolves throughout our lives, learning from past experiences, but also responding to the physiological challenges of getting older. As a result, <a href="https://www.nature.com/articles/nri.2016.90">sex differences</a> in the immune system can be seen from birth through puberty into adulthood and <a href="https://academic.oup.com/jleukbio/advance-article/doi/10.1093/jleuko/qiad053/7190870">old age</a>.</p> <p>Why do these differences occur? The first part of answering this question involves the X chromosome. Females have two X chromosomes, while males have one X and one Y chromosome. The <a href="https://pubmed.ncbi.nlm.nih.gov/20651746/">X chromosome</a> contains the largest number of immune-related genes.</p> <p>The X chromosome also has <a href="https://link.springer.com/article/10.1007/s00018-020-03526-7">around 118 genes</a> from a gene family that are able to stop the expression of other genes, or change how proteins are made, including those required for immunity. These gene-protein regulators are known as microRNA, and there are only <a href="https://pubmed.ncbi.nlm.nih.gov/24808907/">two microRNA genes</a> on the Y chromosome.</p> <p>The X chromosome has <a href="https://www.genome.gov/about-genomics/fact-sheets/X-Chromosome-facts">more genes overall</a> (around 900) than the Y chromosome (around 55), so female cells have evolved to switch off one of their X chromosomes. This is not like turning off a light switch, but more like using a dimmer.</p> <p>Around <a href="https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-019-5507-6">15-25% of genes</a> on the silenced X chromosome are expressed at any given moment in any given cell. This means female cells can often express more immune-related genes and gene-protein regulators than males. This generally means a faster clearance of pathogens in females than males.</p> <p>Second, men and women have <a href="https://www.frontiersin.org/articles/10.3389/fimmu.2020.604000/full">varying levels</a> of different sex hormones. Progesterone and testosterone are broadly considered to limit immune responses. While both hormones are produced by males and females, progesterone is found at higher concentrations in non-menopausal women than men, and testosterone is much higher in men than women.</p> <p>The role of <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533072/">oestrogen</a>, one of the main female sex hormones, is more complicated. Although generally oestrogen <a href="https://www.sciencedirect.com/science/article/abs/pii/S000887491500026X?via%3Dihub">enhances immune responses</a>, its levels vary during the menstrual cycle, are high in pregnancy and low after menopause.</p> <p>Due in part to these genetic and hormonal factors, pregnancy and the years following are associated with heightened immune responses to external challenges such as infection.</p> <p>This has been regarded as an <a href="https://www.nature.com/articles/nri.2016.90">evolutionary feature</a>, protecting women and their unborn children during pregnancy and enhancing the mother’s survival throughout the child-rearing years, ultimately ensuring the survival of the population. We also see this pattern in <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628977/">other species</a> including insects, lizards, birds and mammals.</p> <h2>What does this all mean?</h2> <p>With women’s heightened immune responses to infections comes an increased risk of certain diseases and prolonged immune responses after infections.</p> <p>An <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328995/">estimated 75-80%</a> of all immune-mediated inflammatory diseases <a href="https://pubmed.ncbi.nlm.nih.gov/32542149/">occur in females</a>. Diseases more common in women include multiple sclerosis, <a href="https://www.nature.com/articles/nri2815">rheumatoid arthritis</a>, lupus, Sjogren’s syndrome, and <a href="https://www.nature.com/articles/nri.2016.90">thyroid disorders</a> such as Graves disease.</p> <p>In these diseases, the immune system is continuously fighting against what it sees as a foreign agent. However, often this perceived threat is not a foreign agent, but cells or tissues from the host. This leads to tissue damage, pain and immobility.</p> <p>Women are also prone to chronic inflammation following infection. For example, after infections with <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818468/">Epstein Barr virus</a> or <a href="https://www.liebertpub.com/doi/10.1089/jwh.2008.1193">Lyme disease</a>, they may go on to develop <a href="https://www.nhs.uk/conditions/chronic-fatigue-syndrome-cfs/">chronic fatigue syndrome</a>, another condition that affects more women than men.</p> <p>This is one possible explanation for the heightened risk among <a href="https://www.frontiersin.org/articles/10.3389/fresc.2023.1122673/full">pre-menopausal women</a> of developing long COVID following infection with SARS-CoV-2, the virus that causes COVID.</p> <p>Research has also revealed the presence of auto-antibodies (antibodies that attack the host) in patients with long COVID, suggesting it might be an <a href="https://www.sciencedirect.com/science/article/pii/S1568997221000550">autoimmune disease</a>. As women are more susceptible to autoimmune conditions, this could potentially explain the sex bias seen.</p> <p>However, the exact causes of long COVID, and the reason women may be at greater risk, are yet to be defined.</p> <p>This paints a bleak picture, but it’s not all bad news. Women typically mount <a href="https://pubmed.ncbi.nlm.nih.gov/24966191/">better vaccine responses</a> to several common infections (for example, influenza, measles, mumps, rubella, hepatitis A and B), producing higher antibody levels than men.</p> <p>One study showed that women vaccinated with half a dose of flu vaccine produced the same amount of antibodies compared to men vaccinated with <a href="https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/773453">a full dose</a>.</p> <p>However, these responses <a href="https://www.nature.com/articles/nri.2016.90">decline as women age</a>, and particularly <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954964/">after menopause</a>.</p> <p>All of this shows it’s vital to consider sex when designing studies examining the immune system and treating patients with immune-related diseases.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/208802/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><em><a href="https://theconversation.com/profiles/helen-mcgettrick-1451122">Helen McGettrick</a>, Reader in Inflammation and Vascular Biology, <a href="https://theconversation.com/institutions/university-of-birmingham-1138">University of Birmingham</a> and <a href="https://theconversation.com/profiles/asif-iqbal-1451123">Asif Iqbal</a>, Associate Professor in Inflammation Biology, <a href="https://theconversation.com/institutions/university-of-birmingham-1138">University of Birmingham</a></em></p> <p><em>Image credits: Getty Images</em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/how-biological-differences-between-men-and-women-alter-immune-responses-and-affect-womens-health-208802">original article</a>.</em></p>

Body

Placeholder Content Image

“Done with the vaccine”: Karl Stefanovic blasts fifth booster

<p>Karl Stefanovic has once again sparked controversy after declaring he is “done with the vaccine.”</p> <p>Karl shocked viewers after expressing concerns that the jab could cause “heart issues” as the Australian Technical Advisory Group (ATAGI) updated its vaccine recommendations. </p> <p>According to the ATAGI, as of February 20, anyone aged 18 and over who has not had the COVID vaccine or has not contracted the virus in the past six months will be eligible to get another shot - opening up a fourth dose for Aussies aged 19-29 and a fifth dose for those 65 and over. </p> <p>“As you know, I am not a glowing ambassador for more than two shots,” Stefanovic said.</p> <p>The Today show host then questioned whether another dose would be able to fight new strains of the virus, stating he is aware of people “over the age of 60 who are still incredibly nervous about getting it."</p> <p>“The other thing that I am concerned about, if I have another dose, is that I may get complications,” he said. </p> <p>The host’s guest, medical expert Dr Nick Coatsway insisted Australians aged 60 and over “needn’t be” scared of the jab but added that the conceded boosters are only a temporary solution.</p> <p>“Let’s understand the science, if you get a fifth dose your protection is enhanced for around about 8-12 weeks and then it returns after the fourth dose or the third dose,” Dr Coatsworth said.</p> <p>The ATAGI has again emphasised the importance of Aussies who are already eligible, including people over 65, to get their booster in 2023 as they remain at high risk of severe disease and death from COVID. </p> <p>Currently, there is no additional booster available to those 18 and below, with the exception of children aged 5-17 who are at high risk of developing a severe illness.</p> <p><em>Image credit: Getty</em></p>

TV

Placeholder Content Image

Why does my back get so sore when I’m sick? The connection between immunity and pain

<p><em><a href="https://theconversation.com/profiles/joshua-pate-1399299">Joshua Pate</a>, <a href="https://theconversation.com/institutions/university-of-technology-sydney-936">University of Technology Sydney</a> and <a href="https://theconversation.com/profiles/mark-hutchinson-105409">Mark Hutchinson</a>, <a href="https://theconversation.com/institutions/university-of-adelaide-1119">University of Adelaide</a></em></p> <p>Have you ever wondered why your back aches when you’re down with the flu or a cold? Or COVID?</p> <p>This discomfort, common during many illnesses, is not just a random symptom. It’s a result of complex interactions between your immune system and your brain called the “<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314453/">neuroimmune synapse</a>”.</p> <p>A fascinating and yet-to-be-understood consequence of this conversation between the immune and brain systems during sickness is that it is particularly noticeable in the <a href="https://academic.oup.com/brain/article/145/3/1098/6370954">lower back</a>. This is thought to be one of the body’s most sensitive regions to neuroimmune threats.</p> <h2>Immunology basics</h2> <p>Our immune system is a double-edged sword. Yes, it fights off infections for us – but it also makes us acutely aware of the job it is doing.</p> <p>When our body detects an infection, our immune system releases molecules including signalling proteins called <a href="https://www.researchgate.net/publication/227831648_The_functions_of_cytokines_and_their_uses_in_toxicology">cytokines</a>. These proteins coordinate our immune system to fight off the infection and talk to our brain and spinal cord to <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2740752/#:%7E:text=Production%20of%20proinflammatory%20cytokines%20induces,to%20depression%20in%20vulnerable%20individuals.">change our behaviour</a> and physiology.</p> <p>This can result in symptoms like fatigue, loss of appetite, fever and increased sensitivity to pain. Classically, we think of this as a beneficial behavioural change to help us conserve energy to fight off the infection. It’s why we often feel the need to rest and withdraw from our usual activities when we’re sick – and also why we are grumpier than usual.</p> <h2>Invisibly small changes</h2> <p>Part of this self-protective response is a change in how we perceive threats, including sensory stimuli.</p> <p>When we are sick, touch can become painful and muscles can ache. Many changes in behaviour and sensory systems are <a href="https://doi.org/10.1159/000521476">believed</a> to have origins at the nanoscale. When molecular changes occur in part of the brain linked to cognition or mood, we think and feel differently. If these neuroimmune synapse changes happen in the sensory processing regions of the brain and spinal cord, we feel more pain.</p> <p>Such sensory changes, known as <a href="https://www.iasp-pain.org/resources/fact-sheets/allodynia-and-hyperalgesia-in-neuropathic-pain/#:%7E:text=Allodynia%20is%20pain%20due%20to,stimulus%20that%20normally%20provokes%20pain.">allodynia and hyperalgesia</a>, can lead to heightened pain sensitivity, even in areas not directly affected by the infection – <a href="https://www.sciencedirect.com/science/article/abs/pii/S0889159114001731?via%3Dihub">such as the lower back</a>.</p> <h2>Immune memories</h2> <p>This immune response happens with a range of bacterial infections and viruses like COVID or the flu. In fact, the sick feeling we sometimes get after a vaccination is the good work our immune system is doing to contribute to <a href="https://theconversation.com/you-cant-get-influenza-from-a-flu-shot-heres-how-it-works-118916">a protective immune memory</a>.</p> <p>Some of that immune-cellular conversation also alerts our brains that we are sick, or makes us think we are.</p> <p>After some viral infections, the sick feeling persists longer than the virus. We are seeing a long-term response to COVID in some people, termed <a href="https://theconversation.com/when-does-covid-become-long-covid-and-whats-happening-in-the-body-when-symptoms-persist-heres-what-weve-learnt-so-far-188976">long COVID</a>.</p> <p>Women, who generally have a <a href="https://www.nature.com/articles/nri.2016.90">stronger immune response</a> than men, may be more likely to <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937378/">experience pain symptoms</a>. Their heightened immune response (while beneficial in resisting infections) also predisposes women to a higher risk of inflammatory conditions like <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980266/">autoimmune diseases</a>.</p> <h2>When to worry and what to do</h2> <p>If the pain is severe, persistent, or accompanied by other concerning symptoms, seek medical attention. Mild to moderate pain is a common symptom during illness and we often notice this in the lower back. The good news is it usually subsides as the infection clears and the sickness resolves.</p> <p>While treating the underlying infection is crucial, there are also ways to dial down sickness-induced neuroimmune pain.</p> <p>Maintaining a diverse microbiome (the collection of microorganisms living in and on your body) by <a href="https://pubmed.ncbi.nlm.nih.gov/31704402/">eating well and getting outside</a> can help. Getting quality sleep, staying hydrated and minimising inflammation <a href="https://karger.com/bbe/article/97/3-4/197/821576/Sickness-and-the-Social-Brain-How-the-Immune">helps too</a>.</p> <p>Amazingly, there is <a href="https://pubmed.ncbi.nlm.nih.gov/34404209/">research</a> suggesting your grandmother’s traditional chicken broth recipe decreases the immune signals at the neuroimmune synapse.</p> <p>Scientists are also <a href="https://pubmed.ncbi.nlm.nih.gov/24799686/">showing</a> mindfulness meditation, cold water therapy and controlled breathing can drive profound cellular and molecular changes to help activate bodily systems like the autonomic nervous system and alter the immune response. These practices might not only help manage pain but also add an anti-inflammatory component to the immune response, reducing the severity and duration of sickness.</p> <p>Heat treatment (with a pack or hot water bottle) might <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401625/">provide some relief</a> due to increased circulation. Over-the-counter pain relief maybe also be helpful but seek advice if you are taking other medications.</p> <h2>All in the mind?</h2> <p>Is this all mind over matter? A little of yes and a lot of no.</p> <p>The little of yes comes from <a href="https://pubmed.ncbi.nlm.nih.gov/26194270/">research</a> supporting the idea that if you expect your breathing, meditation and cold bath therapy to work, it may well make a difference at the cellular and molecular level.</p> <p>But by understanding the mechanisms of back pain during illness and by using some simple strategies, there is hope to manage this pain effectively. Always remember to seek medical help if your symptoms are severe or persist longer than expected. Your health and comfort are paramount.<!-- Below is The Conversation's page counter tag. Please DO NOT REMOVE. --><img style="border: none !important; box-shadow: none !important; margin: 0 !important; max-height: 1px !important; max-width: 1px !important; min-height: 1px !important; min-width: 1px !important; opacity: 0 !important; outline: none !important; padding: 0 !important;" src="https://counter.theconversation.com/content/207222/count.gif?distributor=republish-lightbox-basic" alt="The Conversation" width="1" height="1" /><!-- End of code. If you don't see any code above, please get new code from the Advanced tab after you click the republish button. The page counter does not collect any personal data. More info: https://theconversation.com/republishing-guidelines --></p> <p><em><a href="https://theconversation.com/profiles/joshua-pate-1399299">Joshua Pate</a>, Senior Lecturer in Physiotherapy, <a href="https://theconversation.com/institutions/university-of-technology-sydney-936">University of Technology Sydney</a> and <a href="https://theconversation.com/profiles/mark-hutchinson-105409">Mark Hutchinson</a>, Professor, <a href="https://theconversation.com/institutions/university-of-adelaide-1119">University of Adelaide</a></em></p> <p><em>Image credits: Getty Images</em></p> <p><em>This article is republished from <a href="https://theconversation.com">The Conversation</a> under a Creative Commons license. Read the <a href="https://theconversation.com/why-does-my-back-get-so-sore-when-im-sick-the-connection-between-immunity-and-pain-207222">original article</a>.</em></p>

Caring

Placeholder Content Image

Did COVID harm my immune system?

<p>So you’ve had COVID and have now recovered. You don’t have ongoing symptoms and luckily, you don’t seem to have developed <a href="https://theconversation.com/long-covid-how-researchers-are-zeroing-in-on-the-self-targeted-immune-attacks-that-may-lurk-behind-it-169911" target="_blank" rel="noopener">long COVID</a>.</p> <p>But what impacts has COVID had on your overall immune system?</p> <p>It’s early days yet. But growing evidence suggests there are changes to your immune system that may put you at risk of other infectious diseases.</p> <p>Here’s what we know so far.</p> <h2>A round of viral infections</h2> <p>Over this past winter, many of us have had what seemed like a <a href="https://theconversation.com/why-do-i-and-my-kids-get-so-many-colds-and-with-all-this-covid-around-should-we-be-isolating-too-179302" target="_blank" rel="noopener">continual round</a> of viral illness. This may have included COVID, <a href="https://www.who.int/health-topics/influenza-seasonal#tab=tab_1" target="_blank" rel="noopener">influenza</a> or infection with <a href="https://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/symptoms-causes/syc-20353098" target="_blank" rel="noopener">respiratory syncytial virus</a>. We may have recovered from one infection, only to get another.</p> <p>Then there is the re-emergence of infectious diseases globally such as <a href="https://theconversation.com/we-need-to-talk-about-monkeypox-without-shame-and-blame-188295" target="_blank" rel="noopener">monkeypox</a> or <a href="https://theconversation.com/the-latest-polio-cases-have-put-the-world-on-alert-heres-what-this-means-for-australia-and-people-travelling-overseas-188989" target="_blank" rel="noopener">polio</a>.</p> <p>Could these all be connected? Does COVID somehow weaken the immune system to make us more prone to other infectious diseases?</p> <p>There are <a href="https://www.sciencedirect.com/science/article/pii/B9780128009475000168?via%3Dihub" target="_blank" rel="noopener">many reasons</a> for infectious diseases to emerge in new locations, after many decades, or in new populations. So we cannot jump to the conclusion COVID infections have given rise to these and other viral infections.</p> <p>But evidence is building of the negative impact of COVID on a healthy individual’s immune system, several weeks after symptoms have subsided.</p> <h2>What happens when you catch a virus?</h2> <p>There are three possible outcomes after a viral infection:</p> <p>1) your immune system clears the infection and you recover (for instance, with <a href="https://www.healthychildren.org/English/health-issues/conditions/ear-nose-throat/Pages/Rhinovirus-Infections.aspx" target="_blank" rel="noopener">rhinovirus</a> which causes the common cold)</p> <p>2) your immune system fights the virus into “latency” and you recover with a virus dormant in our bodies (for instance, <a href="https://www.healthdirect.gov.au/chickenpox" target="_blank" rel="noopener">varicella zoster virus</a>, which causes chickenpox)</p> <p>3) your immune system fights, and despite best efforts the virus remains “chronic”, replicating at very low levels (this can occur for <a href="https://www.who.int/news-room/fact-sheets/detail/hepatitis-c" target="_blank" rel="noopener">hepatitis C virus</a>).</p> <p>Ideally we all want option 1, to clear the virus. In fact, most of us <a href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-022-00856-w" target="_blank" rel="noopener">clear SARS-CoV-2</a>, the virus that causes COVID. That’s through a complex process, using many different parts of our immune system.</p> <p>But international evidence suggests changes to our immune cells after SARS-CoV-2 infection may have other impacts. It may affect our ability to fight other viruses, as well as other pathogens, such as bacteria or fungi.</p> <h2>How much do we know?</h2> <p>An <a href="https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-021-02228-6" target="_blank" rel="noopener">Australian study</a> has found SARS-CoV-2 alters the balance of immune cells up to 24 weeks after clearing the infection.</p> <p>There were changes to the relative numbers and types of immune cells between people who had recovered from COVID compared with healthy people who had not been infected.</p> <p>This included changes to cells of the <a href="https://www.khanacademy.org/test-prep/mcat/organ-systems/the-immune-system/a/innate-immunity" target="_blank" rel="noopener">innate immune system</a> (which provides a non-specific immune response) and the <a href="https://www.ncbi.nlm.nih.gov/books/NBK21070/" target="_blank" rel="noopener">adaptive immune system</a> (a specific immune response, targeting a recognised foreign invader).</p> <p><a href="https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009742" target="_blank" rel="noopener">Another study</a> focused specifically on <a href="https://www.immunology.org/public-information/bitesized-immunology/cells/dendritic-cells" target="_blank" rel="noopener">dendritic cells</a> – the immune cells that are often considered the body’s “first line of defence”.</p> <p>Researchers found fewer of these cells circulating after people recovered from COVID. The ones that remained were less able to activate white blood cells known as <a href="https://www.britannica.com/science/T-cell" target="_blank" rel="noopener">T-cells</a>, a critical step in activating anti-viral immunity.</p> <p>Other studies have found different impacts on T-cells, and other types of white blood cells known as <a href="https://askabiologist.asu.edu/b-cell" target="_blank" rel="noopener">B-cells</a> (cells involved in producing antibodies).</p> <p>After SARS-CoV-2 infection, one study <a href="https://doi.org/10.1172/JCI140491" target="_blank" rel="noopener">found evidence</a> many of these cells had been activated and “exhausted”. This suggests the cells are dysfunctional, and might not be able to adequately fight a subsequent infection. In other words, sustained activation of these immune cells after a SARS-CoV-2 infection may have an impact on other inflammatory diseases.</p> <p><a href="https://www.nature.com/articles/s41392-021-00749-3#citeas" target="_blank" rel="noopener">One study</a> found people who had recovered from COVID have changes in different types of B-cells. This included changes in the cells’ metabolism, which may impact how these cells function. Given B-cells are critical for producing antibodies, we’re not quite sure of the precise implications.</p> <p>Could this influence how our bodies produce antibodies against SARS-CoV-2 should we encounter it again? Or could this impact our ability to produce antibodies against pathogens more broadly – against other viruses, bacteria or fungi? The study did not say.</p> <h2>What impact will these changes have?</h2> <p>One of the main concerns is whether such changes may impact how the immune system responds to other infections, or whether these changes might worsen or cause other chronic conditions.</p> <p>So more work needs to be done to understand the long-term impact of SARS-CoV-2 infection on a person’s immune system.</p> <p>For instance, we still don’t know how long these changes to the immune system last, and if the immune system recovers. We also don’t know if SARS-CoV-2 triggers other chronic illnesses, such as <a href="https://www.healthdirect.gov.au/chronic-fatigue-syndrome-cfs-me" target="_blank" rel="noopener">chronic fatigue syndrome</a> (myalgic encephalomyelitis). Research into this is ongoing.</p> <p>What we do know is that having a healthy immune system and being vaccinated (when a vaccine has been developed) is critically important to have the best chance of fighting any infection.</p> <p><strong>This article originally appeared on <a href="https://theconversation.com/ive-had-covid-and-am-constantly-getting-colds-did-covid-harm-my-immune-system-am-i-now-at-risk-of-other-infectious-diseases-188899" target="_blank" rel="noopener">The Conversation</a>.</strong></p> <p><em>Image: Shutterstock</em></p>

Body

Placeholder Content Image

Arctic cod liver oil for immune vitality and healthy ageing

<p>Cod liver oil has been used for centuries in Scandinavian societies to help people, young and old, stay healthy throughout the year. Fresh cod liver oil is an excellent source of the omega-3 fatty acids EPA and DHA. Unlike most fish oil products, cod liver oil is unique in that it naturally contains a higher ratio of DHA to EPA, and typically delivers omega-3s in the triglyceride molecular form, the best form for their absorption by the body. Both EPA and DHA play vital roles in aspects of healthy ageing and immune function by influencing muscle and bone mass, mobility, energy, immune responses, and cognitive performance. Ensuring adequate intake of omega-3s with cod liver oil is an easy lifestyle change that can have a positive effect on many aspects of health. Here are some of the most notable omega-3 benefits of cod liver oil (a.k.a. CLO).</p> <p><strong>Omega-3s in CLO can support immune health via the gut </strong></p> <p>Having an overabundance of unhealthy gut bacteria can impair the immune system and accelerate the ageing process. Diet and lifestyle choices—including omega-3 consumption—are key factors for helping to establish a favourable environment for beneficial gut bacteria. Some studies have shown that increased consumption of omega-3s helps promote the growth of “good bacteria” in your gut, while other studies have shown a positive connection between adequate amounts of beneficial gut bacteria and a healthier immune response.</p> <p><strong>Omega-3 intake may influence muscle and bone strength</strong></p> <p>As we age, our immune system produces higher blood levels of inflammatory proteins that may impair muscle and bone health. Omega-3s supplements may support healthier blood levels of these age-associated proteins. Several studies report that people with higher dietary intake of omega-3s tend to have stronger muscles, increased exercise capacity, and denser bones. So, consider a cod liver oil for musculoskeletal health.</p> <p><strong>Omega-3s may help counter the effects of stress </strong></p> <p>Chronic stress increases the hormone cortisol, which can negatively impact immune health, especially if it remains elevated over a period of time. Some research studies have shown that omega-3 supplements may reduce the body’s production of cortisol. Furthermore, people who are “stressed out” tend to already have lower blood levels of the omega-3s EPA and DHA, potentially making it even more important for these individuals to consume supplemental omega-3s in order to keep from getting sick.</p> <p><strong>Omega-3s in CLO provide the building blocks for lasting, healthy skin </strong></p> <p>The skin is the largest organ in the body that also contains significant amounts of omega-3s. Due to years of exposure to ultraviolet light, toxins, and various irritants, the skin requires nutrients like omega-3s to help counter these stresses at the cellular level. The skin barrier is an important structure that protects the body and helps maintain a youthful appearance. Adequate intake of omega-3s supports skin cell functions, promotes the skin barrier, and increases the skin’s ability to retain water—a primary component of healthy skin. Because a portion of the omega-3s we consume eventually makes its way into the skin, these essential fats are vital for skin health.</p> <p><strong>Omega-3s in CLO support cardiovascular health</strong></p> <p>As we age, blood vessels stiffen, and blood pressure tends to increase, which places additional stress on the heart. Studies suggest that diets rich in omega-3s support healthy blood vessels, and several have reported that omega-3 supplements promote positive blood vessel health scores. Additionally, preliminary research suggests that omega-3 fatty acids may also help reduce oxidative stress within the blood vessels, promoting an optimal environment for the vasculature.</p> <p><strong>Choosing the right cod liver oil </strong></p> <p>Because most CLO is non-concentrated, these supplements offer omega-3s in the triglyceride molecular form, the same form in which EPA and DHA naturally exist in fish, and the form that ensures optimal digestion and absorption of omega-3s by the body. If you are ever unsure about the particular form of a CLO supplement (or any fish oil supplement), check the brand’s website or call their customer service department. This information is important, and should be easy for them to provide.</p> <p>It is also a good idea to select a CLO product that is from wild-caught sustainable cod, and that does not contain synthetic additives. Arctic cod from Norway are often sourced using small boats owned and operated by independent cod fishermen, so demand for Arctic cod supports local fishing communities. Also, these boats leave and return daily which means they have a much shorter transport time from catch to processing than larger trawling vessels. This short time helps maximise fish oil freshness, and the efficacy of the omega-3 fats in Arctic Cod Liver Oil.</p> <p>In closing, CLOs have many unique benefits, but do not take our word for it – try it and see for yourself.</p> <p><strong>Use the code HEALTHYME when ordering online and get your delivery freight free. Only for a limited time. Order at </strong><a href="https://bit.ly/3FkXAFE" target="_blank" rel="noopener"><strong>TheraHealth.com.au</strong></a><strong> or find a local </strong><a href="https://bit.ly/3vJY054" target="_blank" rel="noopener"><strong>stockist near you here</strong></a><strong>.</strong></p> <p><img class="alignnone size-full wp-image-59001" src="https://oversixtydev.blob.core.windows.net/media/2022/05/Author_O60.jpg" alt="" width="1280" height="440" /></p> <p><em><strong>This is a sponsored article produced in partnership with <a href="https://bit.ly/3FkXAFE" target="_blank" rel="noopener">Thera Health</a>.</strong></em></p> <p><em><strong>Image: Shutterstock</strong></em></p>

Body

Placeholder Content Image

Three reasons you haven’t caught Covid yet

<p dir="ltr">Most of us have been in close contact with someone who contracted Covid but never tested positive ourselves.</p> <p dir="ltr">It raises questions as to why you would not test positive yourself despite being in the same room as a positive case, sharing food and drink despite how infectious the virus is.</p> <p dir="ltr">There are three possible reasons as to why you still haven’t caught Covid, despite the situation leaving doctors stumped. </p> <p dir="ltr">Australian National University lecturer and epidemiologist Dr Katrina Roper helps explain the three main reasons why some don’t test positive. </p> <p dir="ltr"><strong>Common cold</strong></p> <p dir="ltr">Before Covid, we’d all be exposed to the common cold which would help build immunity against other viruses. </p> <p dir="ltr">“Having a prior infection to another cold virus can confer some protection to Covid, or other respiratory viruses,” Dr Roper told <a href="https://www.news.com.au/lifestyle/health/health-problems/a-doctor-explains-why-you-havent-caught-covid-yet/news-story/d57a08a08278abf27f43c29fcfe87196" target="_blank" rel="noopener">news.com.au</a>.</p> <p dir="ltr">”Exposure to other respiratory viruses can prime parts of the immune system, leading to better defence against infection by the SARS CoV-2 infection”.</p> <p dir="ltr">Research published in the Nature Communications journal in January 2022, confirmed the theory that being exposed to Covid won’t always cause an infection.</p> <p dir="ltr">“Being exposed to the SARS-CoV-2 virus doesn’t always result in infection, and we’ve been keen to understand why,” lead author Dr Rhia Kundu wrote.</p> <p dir="ltr">“We found that high levels of pre-existing T cells, created by the body when infected with other human coronaviruses like the common cold, can protect against COVID-19 infection.”</p> <p dir="ltr">Immunologist Professor Stuart Tangye insists that there’s also a possibility that you were infected with Covid but you didn’t know it. </p> <p dir="ltr"><strong>Your immune system</strong></p> <p dir="ltr">When it comes to avoiding Covid it could be that your immune system is pretty strong, or the vaccine worked better for you. </p> <p dir="ltr">Dr Roper however did point out that it could also all depend on the individuals’ circumstance - such as their age, weight and how healthy they are.</p> <p dir="ltr">She noted that even the healthiest of people could still have weakened immune systems - citing professional athletes who push themselves and in turn feel worse afterwards. </p> <p dir="ltr"><strong>The exposure</strong></p> <p dir="ltr">Again, everyone has been exposed differently to Covid and while some may have contracted it, you didn’t. </p> <p dir="ltr">The circumstances of where you are could be affected such as a large house but only two people living there, giving you ample space to stay away despite sharing the same areas.</p> <p dir="ltr"><strong>Genetics</strong></p> <p dir="ltr">Professor Tangye suggested a fourth reason as to why you haven’t contracted Covid despite your exposure.</p> <p dir="ltr">Put simply, your genetics. </p> <p dir="ltr">“There are going to be people who are less susceptible to viral infection because they have differences in their genes, such as genes that are important for viral entry into your cells,” he said.</p> <p dir="ltr"><em>Image: Shutterstock</em></p>

Caring

Placeholder Content Image

A million Aussies over 60 yet to have booster as cases tipped to rise

<p>With coronavirus cases in Australia seeing a steep uptick in recent days, state health ministers have warned over-60s to get their booster vaccine. </p> <p>Cases are expected to double in the coming weeks, with over 900,000 Aussies in the 60-plus age bracket yet to book in for the latest jab.</p> <p>NSW Health Minister Brad Hazzard has said he does not support reinstating pandemic lockdown restrictions, but is encouraging everyone to have their booster as soon as possible. </p> <p>“What we’ve seen in the last few years is that as soon as positive cases start going up, people start getting vaccinated. It would make a lot more sense if they got [boosted] now, so they are less likely to catch the virus and be part of those rising numbers,” Mr Hazzard said.</p> <p>NSW reported a dramatic increase in Covid cases on Wednesday, with 30,402 infections after a data glitch meant about 10,000 tests on Sunday and Monday failed to be added to daily case counts.</p> <p>Despite the data glitch, the sudden uptick in cases has health officials concerned that many people are getting complacent in their thoughts towards the virus. </p> <p>“Boosters are our passage to safety and normal life, go and get it, don’t muck around.”</p> <p>In NSW, more than 330,000 people over the age of 60 have yet to have the jab, as Mr Hazzard warned the vulnerable group to be protected. </p> <p>“We’ve got just over 300,000 people in the 60-plus age bracket who are still not boosted … that makes them particularly vulnerable. They’re the grandmothers and grandfathers, the aunts, the uncles that young people are going to see. We need the whole population boosted,” he said.</p> <p><em>Image credits: Getty Images</em></p>

Caring

Placeholder Content Image

Why millions of Aussies have not gotten boosters

<p>A new study has revealed that adults across Australia are proving very hesitant to receive their Covid-19 boosters.</p> <p>The analysis shows the hesitancy is not from vaccine misinformation or resistance, but from being completely disengaged from consuming further information about Covid-19.</p> <p>The survey conducted by the Australian National University shows less than half of all double vaccinated Australians aged 18 and over have had their booster.<br />It also found young Australians aged 18-24, Indigenous Australians, people with low education, and those who live in disadvantaged areas, are less likely to have received the third shot.</p> <p>In January, the ANU survey of more than 3400 adults found about four-in-10 Australians or 41.5% had received a third dose of a COVID-19 vaccine.</p> <p>Study co-author Nicholas Biddle says 65.4% of people surveyed confirmed they would definitely get a booster compared to 71.9% in a survey previously conducted in October.</p> <p>'The findings suggest that booster uptake is not due to active resistance ... but rather because people either do not have that much information about the need for a third dose or because they have made a judgement that it is not necessary for them,' he said.</p> <p>'The experience of the first two doses, particularly side effects, may also have made some reluctant to seek out a third dose.'</p> <p>Although Australia had high success nationally with the initial rollout, where 94.4% of people over 16 years have had two doses, the ANU analysis shows there is no guarantee that success will be repeated in the booster rollout.</p> <p>'There is a very large proportion of adult Australians who are eligible for a booster but have not yet done so, with many of these individuals likely to have waning immunity from their first two doses,' Professor Biddle said.</p> <p>This information coincides with the restrictions lifting, where wearing a mask and checking in will become a thing of the past. Nationally, more than 25,000 COVID-19 infections were recorded on Thursday. </p> <p><em>Image: Getty </em></p>

Caring

Placeholder Content Image

New booster vaccine approved in Australia

<p dir="ltr">An additional vaccine has been <a href="https://www.9news.com.au/national/astrazeneca-booster-shots-provisionally-approved-australia-therapeutic-goods-administration/cb666fd3-dff2-4603-8a56-663b7ad0b225" target="_blank" rel="noopener">granted provisional approval</a> to be used as a booster shot by the Therapeutic Goods Administration (TGA).</p><p dir="ltr">The TGA announced that a vaccine produced by AstraZeneca, called Vaxzevria, could be administered to individuals over the age of 18 who are yet to receive their third, ‘booster’ dose of a COVID-19 vaccine.</p><p dir="ltr">However, the TGA continues to recommend that Australians choose Moderna or Pfizer over the newly-approved jab.</p><p dir="ltr">“The third (booster) dose may be given if clinically indicated with reference to official guidance regarding the use of a heterologous third dose (e.g. mRNA vaccine),” it said in a statement.</p><p dir="ltr">“This means that the decision to receive Vaxzevria as a booster must be made in consultation with a medical professional.”</p><p dir="ltr">Dr Vinod Balasubramaniam, a virologist from Monash University’s Jeffrey Cheah School of Medicine and Health Sciences in Malaysia, said the addition of a third vaccine is particularly important as the world battles the Omicron variant.</p><p dir="ltr">“It’s important to increase the vaccine portfolio in the fight against COVID-19, in particular against the current highly contagious Omicron variant, a multi-pronged approach is definitely needed for us to win the war,” he <a href="https://www.scimex.org/newsfeed/expert-reaction-tga-provisionally-approves-astrazeneca-boosters-for-ages-18" target="_blank" rel="noopener">said</a>.</p><p dir="ltr">“Diversifying the vaccine portfolio in including AstraZeneca vaccines as part of the booster dose regimen is important, especially when used as a mix-and-match for individuals who experienced adverse reactions with their primary vaccinations with other types of vaccines.”</p><p dir="ltr">Dr Andy Files, a senior research fellow at the Menzies Institute for Medical Research within the University of Tasmania, agreed and noted that the mix-and-match approach has been proved as an effective way of protecting people from the virus.</p><p dir="ltr">“From a basic immunology perspective, swapping vaccines should help to focus the immune response on the SARS-CoV-2 spike protein encoded in the vaccines, rather than the other components of the vaccine, thus providing the intended boost in protection against the coronavirus,” he explained.</p><p dir="ltr">“The AstraZeneca booster will be most useful for people that had strong side effects to the mRNA vaccines or have histories of myocarditis or pericarditis.”</p><p><span id="docs-internal-guid-7a08a62b-7fff-6267-485c-f7fb04a89364"></span></p><p dir="ltr"><em>Image: Getty Images</em></p>

Body

Placeholder Content Image

I just recovered from Omicron – how long does my immunity last?

<div class="copy"> <p>If you recently recovered from an <a rel="noreferrer noopener" href="https://cosmosmagazine.com/health/covid/omicron-update-170122/" target="_blank">Omicron infection</a>, do you now have free rein to do whatever you want without risk of reinfection? And if so, for how long?</p> <p>Two main factors affect how well your acquired immunity after Omicron infection will protect you. </p> <p>First, your antibody levels. “If high levels of neutralising antibodies are elicited to Omicron following infection, then we would expect to see some level of protection against reinfection with Omicron, but this is likely to be short-lived,” says Professor Gilda Tachedjian, a virologist at the Burnet Institute and past president of the Australian Virology Society.</p> <p>Generally, a more severe infection generates a higher level of antibodies than an asymptomatic infection, explains Professor Anthony Cunningham, an infectious diseases physician and clinical virologist at the University of Sydney. But when the level of neutralising antibodies begins to drop, your likelihood of reinfection rises.</p> <p>It’s simply too early to know how long Omicron immunity will last, he says.</p> <p>From vaccine studies, we know that antibody levels begin to drop after three to six months. A <a rel="noreferrer noopener" href="https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00219-6/fulltext" target="_blank">recent study</a> published in <em>The Lancet</em> estimated that reinfection by SARS-CoV-2 under endemic conditions would likely occur between three months and five years after peak antibody response.</p> <p>Almost certainly, Cunningham says, there will be a lot of individual variation, similar to what has been observed with previous strains. This variation depends on the severity of the disease you experienced, and whether you have had a vaccine.</p> <p>The second factor: emerging variants. Our waning antibodies may not be able to target any new variants that come along. The Omicron variant, for example, largely evades immunity from past infection and vaccines. A recent <a rel="noreferrer noopener" href="https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-49-Omicron/" target="_blank">report</a> from Imperial College London estimates that the risk of reinfection with Omicron is 5.4 times greater than that of the Delta variant.</p> <p>“The most likely outcome is that you won’t get re-infected with Omicron because the expectation is that the Omicron wave will decline, but then the greatest risk is that another strain comes along,” says Cunningham. “It all depends on what type of strain comes next.”</p> <p>Even if you have had a recent Omicron infection, don’t throw your mask away, warns Cunningham: “The more virus circulates in the world, the more likely it is that we’ll see new strains.”</p> <p>Although protection from reinfection might not last for long, experts think T-cells might come to the rescue.</p> <p>While antibodies directly bind and neutralise virions, preventing an infection, T-cells activate once the infection is established. They target and kill virus-infected cells, helping to clear the infection and reduce its severity. This arm of the immune response tends to be broader than antibodies – and thus more likely to recognise variants, and to last longer, Tachedjian explains.</p> <p>“Hopefully, you will be asymptomatic or have a less severe disease [the second time around].”</p> <em>Image credits: Getty Images </em></div> <div id="contributors"> <p><em>This article was originally published on <a href="https://cosmosmagazine.com/health/covid/immunity-after-omicron-infection/">cosmosmagazine.com</a> and was written by Dr Manuela Callari. </em></p> </div>

Body

Placeholder Content Image

Most common side effect of booster jab explained

<p><em>Image: Getty </em></p> <p>As more Aussies are rolling up their sleeves for their Covid-19 booster shots, reports are emerging of<span> </span><a rel="noopener" href="https://www.oversixty.com.au/health/body/woman-reports-bizarre-side-effect-of-covid-jab" target="_blank">all kinds of bizarre side effects</a>. But there is one in particular that is proving the most common.</p> <p>Most who have received both doses already have an idea of some of the side-effects that can occur, including pain at injection site, tiredness, fever, chills and headaches.</p> <p>However, the more common adverse effect from the third Covid vaccine appear to be swollen lymph nodes. These are the small lumps of tissue that contain white blood cells to help you fight infection by attacking and destroying germs that are carried through the lymph fluid.</p> <p>There are hundreds of lymph nodes throughout the body including in the neck, armpit, chest, abdomen and groin.</p> <p>“Swollen lymph nodes are a normal and known side effect of vaccines and occurs when the immune system is stimulated,” the TGA said, adding it was observed during clinical trials for the Covid-19 vaccines.</p> <p>For Pfizer, it has been found to occur more frequently after a third dose, with about 5% of people reporting experiencing swollen lymph nodes. This is compared to the less than 1% of people who reported this side effect after the first or second doses in the clinical trials.</p> <p>For Moderna, this side effect occurred in up to 10% of people.</p> <p>Swelling may be noticed near the injection site within a few days of the vaccination, for example in an armpit where the lymph nodes are located.</p> <p><strong>What causes the swelling?</strong></p> <p>The Covid-19 vaccines contain spike proteins that start to build when injected into your body. These proteins are then carrying into the lymph nodes, activating some of the white blood cells. Immunology researcher at the Walter and Eliza Hall Institute (WEHI), Joanna Groom, told the ABC some of the white blood cells that are stimulator are known “effector” cells and pump out antibodies that neutralise the virus and therefore multiplying, possibly leading to inflammation.</p> <p>It appears that a fourth Covid-19 booster shot could be on the cards for Australians, with the country’s most senior health official dropping a big hint about additional vaccine doses.</p> <p>Earlier this month, Israel became the first country to begin rolling out a fourth dose of the vaccine. A fourth dose is already recommended for immunocompromised people in Australia.</p>

Body

Placeholder Content Image

COVID concerns drive supplement and vitamin use

<div> <p><em>Image: Getty </em></p> <p><span>Sales of complementary medicines have been driven up by COVID fears, but immune boosting claims for them are doing more harm than good. </span></p> <div class="copy"> <p>In an <a rel="noopener" href="https://www.nps.org.au/australian-prescriber/articles/the-safety-of-commonly-used-vitamins-and-minerals" target="_blank">article</a> published today in <em>Australian Prescriber, </em>University of Queensland Adjunct Associate Professor of Pharmacology Geraldine Moses has warned of major potential harms associated with the use of dietary supplements.</p> <p>“One reason for the persistent popularity of vitamins and minerals is the perception that they are harmless,” says Moses. But that perception masks a troublesome reality.</p> <p>“When it comes to complementary medicines, most consumers are only given information about the possible benefits of these products, and little if anything about risk – and there’s always potential risk.”</p> <p>The advice comes as supplement use is soaring. In July, a US survey claimed that nearly 30% of Americans are now taking more supplements than they were before the COVID-19 pandemic. Commissioned by the US health non-profit <a rel="noopener" href="https://www.samueli.org/" target="_blank">Samueli Foundation</a>, the <a rel="noopener" href="https://theharrispoll.com/" target="_blank">Harris Poll</a> concluded that 76% of US citizens were taking supplements.</p> <p>The article in <em>Australian Prescriber</em> discusses six potential harms of using dietary supplements:</p> <ul> <li>They can have <strong>adverse effects</strong>, particularly at high doses.</li> <li>They can <strong>interact with other medicines</strong>.</li> <li>They <strong>cost money</strong>, which may be better spent on other things.</li> <li>Time spent taking dietary supplements may delay <strong>more effective treatments</strong>.</li> <li>They may <strong>bring false hope</strong> and disappointment.</li> <li>By taking dietary supplements, people <strong>add to the number of medicines they are taking</strong>, increasing the risk of medication error, interactions and adverse effects.</li> </ul> <p>The US survey was small and not based on a probability sample, so more research is required to build an accurate picture. But the trend it highlights is supported by evidence globally of an upturn in supplement use.</p> <p>Accurate figures for Australia are hard to obtain, but market researchers <a rel="noopener" href="https://www.ibisworld.com/au/industry/online-vitamin-supplement-sales/4091/" target="_blank">report</a> that sales of vitamins and supplements soared during the pandemic. </p> <p>The trend suggests that pandemic-related fear may be driving the use of these products, which some experts say are not regulated or evidenced as rigorously as <a rel="noopener" href="https://www.tga.gov.au/registered-medicines" target="_blank">registered medicines</a>. And while the pandemic may have bolstered supplement sales, the scale of their use has always been profound: in 2018, around <a rel="noopener" href="http://www.roymorgan.com/findings/7956-australian-vitamin-market-december-2018-201904260734" target="_blank">a third of Australians</a> – 8.3 million people – reported buying supplements, according to Roy Morgan.</p> <h4><strong>Supplementary harms?</strong></h4> <p>Supplements can be benign and are critical for people with particular conditions or deficiencies, but there are notable cases in which they’ve been shown to cause long-term damage.</p> <p>Just last week, doctors at a Sydney liver transplant centre <a rel="noopener" href="https://insightplus.mja.com.au/2021/27/drug-related-liver-injury-call-for-better-regulation-of-supplements/" target="_blank">went public with concerns</a> that drug-induced liver injuries linked to dietary and herbal supplements were on the rise. </p> <p>Their <a rel="noopener" href="https://www.mja.com.au/journal/2021/215/6/drug-induced-liver-injury-australia-2009-2020-increasing-proportion-non" target="_blank">study</a>, which spanned 2009 to 2020, found that the proportion of drug-induced liver injuries that were caused by supplements (as opposed to things such as paracetamol and other medications) rose from 15% in 2009–11 to 47% in 2018–20. </p> <p>“We observed a link to bodybuilding and weight-loss supplements as has been seen in reports internationally, but also a link to traditional Chinese medicines,” says co-author Simone Strasser, president of the Gastroenterological Society. “Both groups of supplements are rising in popularity in Australia.”</p> <p>Strasser says that in many cases supplement-related drug-induced liver injuries (DILIs) were potentially severe: while 90-day transplant-free survival was 74% for liver injuries caused by paracetamol, it was 59% for those caused by supplements. </p> <p>“There’s an old saying that the difference between a drug and a poison is the dose,” says Moses. “What many people don’t realise is that high doses of some supplements can be dangerous.”</p> <p>Moses says that because consumers aren’t aware of the potential toxicity of supplements, they may be skirting perilously close to the line without even knowing.</p> <p>“Vitamin B6 is the classic one,” Moses says. “In Australia, the toxic dose is considered to be 200mg a day or more, and lots of people that I see now in hospital will be on four products with 50mg in each one, so they’re at the toxic dose, but they’re completely unaware of that.”</p> <p>The authors of the liver-damage study have expressed concern that so many supplements are escaping regulatory oversight by the Therapeutic Goods Administration (TGA), not least, Strasser says, because “not infrequently these compounds were purchased online, bypassing the Australian regulatory system”.</p> <p>Strasser adds that because reporting adverse events associated with supplements to the TGA is voluntary, many severe adverse reactions go unreported.</p> <h4><strong>Health anxiety drives demand</strong></h4> <p>As the pandemic progresses, reports of health anxiety <a rel="noopener" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239023/" target="_blank">naturally rise</a>. A July 2020 <a rel="noopener" href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0236562" target="_blank">study</a> among 5,070 adult Australians of varying ages and from various locations found that 25% were very or extremely worried about contracting COVID-19, and around half (52%) were worried about family and friends contracting the disease.</p> <p>“When people are fearful, especially now with COVID, they will reach out and do whatever they can to assuage their anxiety, including taking natural health products,” Moses says. </p> <div class="newsletter-box"> <p class="h2"><strong>But do supplements work as promised?</strong></p> </div> <p>Ken Harvey, a professor at Bond University’s school of Health Sciences and Medicine and an outspoken critic of pharmaceutical marketing, says that supplements can be helpful in specific cases. For example, pregnant women are encouraged to take folic acid to reduce the risk of foetal defects, and older people may need certain nutritional supplements to make up for deficiencies caused by poor diet, lack of activity and a lack of sunlight. </p> <p>But Harvey says most Australians can get enough of what they need from a reasonably healthy diet, so any vitamin they take will simply be filtered out by the kidneys and excreted in urine, because the body already has enough. </p> <p>Meanwhile, social media and wellness ‘influencers’ are patently contributing to the problem. A 2020 <a rel="noopener" href="https://aacijournal.biomedcentral.com/articles/10.1186/s13223-020-00474-6" target="_blank">study</a> in <em>BMC Allergy, Ashthma and Clinical Immunology </em>found that use of the popular Instagram hashtag #immunebooster increased by over 46% between 15 April and 15 May 2020.</p> <h4><strong>The myth of “immune-boosting” products</strong></h4> <p>One of the most touted phrases by both wellness influencers and supplement brands is ‘immune-boosting’, a term that had become synonymous with “wellness” even before the global pandemic. But how accurate is the term ‘immune-boosting’?</p> <p>Well, not very. According to Harvey, the immune-boosting myth is based on the fact that a lack of vitamins and minerals is known to<em> </em>weaken immunity, for example among malnourished populations. But Harvey says that in Australia, “there is no good evidence of widespread vitamin deficiencies in the population”.</p> <p>In fact, the idea of immune-boosting is based on a misconception about how the immune system works. The immune system is <a rel="noopener" href="https://www.cedars-sinai.org/blog/boosting-your-immune-system.html" target="_blank">better off balanced</a> than boosted – if it could be boosted by supplements (<a rel="noopener" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6673706/#B7" target="_blank">which it can’t</a>), users would experience symptoms of an immune response, such as fever and a runny nose, and in extreme cases would end up very sick.</p> <p>“To ‘boost’ your immune system against specific diseases, you’ve got to either catch one, or you’ve got to be vaccinated,” Harvey says, adding that consumers often buy supplements under the mistaken belief – promoted by some brands – that they will offer immunological benefits.</p> <p>Even more alarming, there is <a rel="noopener" href="https://pubmed.ncbi.nlm.nih.gov/28911953/" target="_blank">evidence</a> that some people may use ‘immune-boosting’ natural remedies as an alternative to vaccinations against viral conditions such as the flu, meaning the immune-boosting myth could hamper the fight against disease.</p> <p>Harvey says the TGA has regulated against advertising that promotes immune-boosting products by reference to the pandemic – but there’s a major loophole, because products can still be marketed as ‘immune-boosting’, provided they don’t mention COVID-19. </p> <h4><strong>So, how <em>are</em> supplements regulated?</strong></h4> <p>Under the TGA’s classification process, there are two major categories of medicines. Registered medicines include all prescription medications and most over-the-counter (OTC) medicines. Prescription medications are considered higher risk, and OTC medicines a lower but still palpable risk, so all registered medicines are assessed by the TGA for quality, safety <em>and </em>efficacy.</p> <p>Efficacy, in pharmacological terms, refers to the ability of a drug to provide the benefits to which it claims, including establishing the dosage required to provide that benefit. <a rel="noopener" href="https://www.nps.org.au/australian-prescriber/articles/efficacy-effectiveness-efficiency" target="_blank">Efficacy is established during clinical trials</a>.</p> <p>Complementary medicines such as supplements fall into the category of <a rel="noopener" href="https://www.tga.gov.au/listed-medicines" target="_blank">listed medicines</a>, which generally contain well-known, low-risk ingredients with long histories of use, such as vitamin and mineral products and sunscreens. These medicines are those that the TGA considers to be generally benign or low risk, so, “listed medicines do not undergo a full pre-market assessment of safety, quality and efficacy,” according to the TGA.</p> <p>The TGA <em>does</em> do yearly post-marketing surveillance on around 150 of the thousands of listed medicines on the Australian market, the results of which can be found in its <a rel="noopener" href="https://www.tga.gov.au/annual-performance-statistics-reports" target="_blank">annual performance statistics reports</a>. </p> <p>A review of the performance statistics over the five years from 2015 to 2020 reveals that around 75% to 80% of the listed medicines tested are found to breach compliance in some way, which would appear to point to what Harvey refers to as a “light-touch regulatory process” for listed medicines.</p> <h4><strong>Where to now?</strong></h4> <p>Approached for comment, the TGA informed <em>Cosmos </em>that enhancements to the listed medicines post-market compliance scheme are coming. </p> <p>But the supplement sector has always been resilient, offering an alluring alternative to Western medicine, whether because the supplements are perceived as low risk, or because of an inherent distrust of public-health messaging.</p> <p>“They [the TGA] have a pretty tough job to do, trying to cover every possible pharmaceutical product throughout Australia,” Moses says. “But I certainly think that with complementary medicines we could do a better job if we required manufacturers to provide consumers with information about potential risks.”</p> <p>Strasser says that a lack of public education is hampering both the TGA and the medical profession’s ability to clamp down on unsafe supplement use.</p> <p>“There is still a perception that supplements are natural and therefore healthy,” she says. “Time after time, patients who experience severe DILI are incredibly surprised that something they purchase over the counter or online with the aim of improving their health could have harmed them.”</p> <!-- Start of tracking content syndication. Please do not remove this section as it allows us to keep track of republished articles --> <img id="cosmos-post-tracker" style="opacity: 0; height: 1px!important; width: 1px!important; border: 0!important; position: absolute!important; z-index: -1!important;" src="https://syndication.cosmosmagazine.com/?id=160279&amp;title=COVID+concerns+drive+supplement+use" alt="" width="1" height="1" /> <!-- End of tracking content syndication --></div> <div id="contributors"> <p><a href="https://cosmosmagazine.com/health/dangers-dietary-supplements/">This article</a> was originally published on <a href="https://cosmosmagazine.com">Cosmos Magazine</a> and was written by <a href="https://cosmosmagazine.com/contributor/amalyah-hart">Amalyah Hart</a>. </p> </div> </div>

Food & Wine

Placeholder Content Image

Government announces shortened booster window

<p dir="ltr">The federal government has announced that the timeframe between the second COVID-19 vaccine and the booster shot has been shortened, from five months to four. The change will come into effect on January 4.</p> <p dir="ltr">This is an additional reduction, following an initial interval of six months in between shots. Furthermore, on January 31, the gap between shots will be reduced to just three months.</p> <p dir="ltr">These changes will enable millions of Australians to receive their booster shots, which are increasingly being seen as necessary to resist the Omicron strain and maintain immunity amidst rising cases across the country, far sooner.</p> <p dir="ltr">This includes over 60s, many of whom were not fully vaccinated until late in the year due to eligibility criteria. Tony Blakeley, an epidemiologist from the University of Melbourne, described the five-month gap between the second and third shots as “bordering on unethical”, particularly for older Australians who received the AstraZeneca vaccine.</p> <p dir="ltr">“AstraZeneca recipients are often 60-plus, they're often more vulnerable, yet they had a vaccine where they had to wait three months between the first and second dose and now they're not eligible,” he explained.</p> <p dir="ltr">The change follows advice from expert vaccination group ATAGI and is in response to the recent spike in cases as the Omicron variant spreads throughout the community. On Friday, Victoria recorded 2095 new cases and eight deaths, while NSW recorded 5612 and one death.</p> <p dir="ltr">Health Minister Greg Hunt explained that cutting the interval down would ensure roughly 7.5 million Australians would be eligible to receive a booster shot by early January, whereas as of Friday, only 3.2 million were eligible.</p> <p dir="ltr">Once the interval is reduced further at the end of January, about 16 million Australians will be eligible to receive their third vaccine. In a press conference on Friday, Mr Hunt said, “These dates have been set out of an abundance of caution to give Australians early continued protection.”</p> <p dir="ltr"><em>Image: Rohan Thomson/Getty Images</em></p>

News

Placeholder Content Image

Should over 60s who received the AstraZeneca get boosters sooner?

<p dir="ltr">Some epidemiologists are calling for the time frame between the second COVID-19 vaccine and the booster to be shortened for those who received the AstraZeneca vaccine.</p> <p dir="ltr">Tony Blakely from the University of Melbourne is one such epidemiologist, and he has highlighted the risk facing those in their 60s who will not be eligible to receive the booster shot for several months, both because of the delay between jabs one and two and the five-month delay between the second jab and the booster.</p> <p dir="ltr">He described the five-month gap as “bordering on unethical”, arguing, “AstraZeneca recipients are often 60-plus, they're often more vulnerable, yet they had a vaccine where they had to wait three months between the first and second dose and now they're not eligible.”</p> <p dir="ltr">Despite this, Prime Minister Scott Morrison refused to adjust the time frame any further, after already reducing it from six months to five. Speaking to the media following an<span> </span><a rel="noopener" href="https://oversixty.com.au/news/news/stay-calm-get-your-booster-pm-delivers-results-of-emergency-cabinet-meeting" target="_blank">emergency National Cabinet meeting</a>, Morrison said, "There's been plenty of discussion about whether the interval should be five months, four months, three months. That will be a decision for the vaccination experts at ATAGI. That is not a decision for myself as prime minister or the premiers and chief ministers."</p> <p dir="ltr">Research suggests vaccines are less effective against the Omicron variant than they were against Delta, and research has also shown that vaccines steadily lost their effectiveness against COVID-19 in the weeks following the second dose. For AstraZeneca, effectiveness fell to 47.3 per cent after 20 weeks, falling even more for over-65s.</p> <p dir="ltr">On the bright side, protection against hospitalisation did not fall as sharply, maintaining 77 per cent effectiveness after 20 weeks and almost 79 per cent effectiveness against death.</p> <p dir="ltr"><a rel="noopener" href="https://www.abc.net.au/news/2021-12-23/covid-astra-zeneca-vaccine-too-soon-for-booster-omicron/100719368" target="_blank">Linda Fisher and her husband Ken</a><span> </span>are some of the members of ‘Generation AZ’ who are concerned about the five-month wait. The Queensland couple have plans to travel to Melbourne next month, and because they are not yet eligible for a booster, having only received their second shot in November, they’re wondering if they’re putting their lives at risk by travelling interstate. They are not due to receive the booster until April.</p> <p dir="ltr">Hassan Vally, an epidemiologist at Deakin University, urged those in vulnerable groups to exercise caution over the holidays. "People who are a bit older and have other comorbidities need to take precautions this Christmas.” Despite this, he stressed that we are not “back to square one” thanks to the Omicron variant, explaining, "Most people have a certain degree of immunity which changes the equation completely from a virus that's spreading in a population with no immunity.</p> <p dir="ltr">“It's important to bring that fear level down a little bit, but at the same time acknowledge that yeah, this is a significant challenge."</p> <p dir="ltr"><em>Image: Morsa Images</em></p>

Caring

Placeholder Content Image

"Stay calm, get your booster": PM delivers results of emergency cabinet meeting

<p><em>Image: 9 News</em></p><p>Prime Minister Scott Morrison has strongly urged Australians to wear masks in indoor public settings as part of a suite of new measures to tackle rising COVID cases across the nation.</p><p><br />Mr Morrison gathered with state and territory leaders from noon on Wednesday as part of an emergency national cabinet meeting to discuss the growing Omicron threat.</p><p>Previously, national cabinet was not scheduled to meet until February 2022, but rising Covid-19 cases, particularly in NSW, prompted the Prime Minister to call a snap meeting.</p><p>The meeting was held virtually, with booster vaccinations and the reintroduction of key restrictions, such as masks, the main topics of discussion.<br />Following the meeting, Morrison said they “had a positive meeting” and that they are taking Omicron very seriously.</p><p>Mr Morrison also said that mask wearing in indoor spaces was highly recommended.</p><p>"Whether it's mandated or not, that's what we should be doing," he said.</p><p>He further encouraged Australians to move gatherings outdoors where possible.</p><p>"People following common sense behaviours is very important."</p><p>Mr Morrison said classification of COVID-19 contacts would be standardised between the states and territories.</p><p>"We must have a common definition, right across the country, of what is a casual contact, and what are the implications of being a casual contact," he said.</p><p>"We cannot have different rules in different places."</p><p>He said experts would make a recommendation on the definition of "close contacts" and "casual contacts" in the next fortnight.</p><p>The Prime Minister said it was not realistic to use QR codes to completely track COVID-19 outbreaks in areas with high case numbers.</p><p>Chief Medical Officer Professor Paul Kelly then said that Australia had not seen a rise in hospitalisations due to Omicron, despite the large increase in case numbers occurring around the country.<br />He went on to say that there is no doubt that Omicron is replacing Delta in NSW.</p><p>The Prime Minister also announced a major change to the booster program as the health system struggles to rollout Australians third doses.</p><p>Mr Morrison on Wednesday declared that General Practitioners and Pharmacists would receive $10 extra from the federal government for administering the booster shot.</p><p>“I can announce that I have advised the premiers and chief ministers today that we will be increasing the payments to GPs and pharmacists,” he said.</p><p>“We'll be increasing them up by $10 a jab.”</p><p>Pharmacists are now expected be reimbursed around $26-29 per jab while GPs will received $27-$50.</p><p>On the issue of wait times at testing sites, Mr Morrison said it was being considered whether PCR tests would be needed for interstate travellers who had no symptoms, or if rapid tests could be adequate.<br />Mr Morrison also said the Doherty Institute would be doing further research, while the National Cabinet would reconvene in a fortnight.</p><p><br />"My main message is to stay calm, get your booster, follow the common-sense behavioural measures."<br />He said it had been agreed Australia was not going back to lockdowns and that Australia was arguably one of the best placed countries in the world to deal with Omicron.</p>

News

Our Partners